Characterization of Silver Nanoparticle-Infused Tissue Adhesive for Ophthalmic Use by Yee, William
San Jose State University
SJSU ScholarWorks
Master's Theses Master's Theses and Graduate Research
Fall 2013
Characterization of Silver Nanoparticle-Infused
Tissue Adhesive for Ophthalmic Use
William Yee
San Jose State University
Follow this and additional works at: https://scholarworks.sjsu.edu/etd_theses
This Thesis is brought to you for free and open access by the Master's Theses and Graduate Research at SJSU ScholarWorks. It has been accepted for
inclusion in Master's Theses by an authorized administrator of SJSU ScholarWorks. For more information, please contact scholarworks@sjsu.edu.
Recommended Citation
Yee, William, "Characterization of Silver Nanoparticle-Infused Tissue Adhesive for Ophthalmic Use" (2013). Master's Theses. 4406.
DOI: https://doi.org/10.31979/etd.2btn-qkw6
https://scholarworks.sjsu.edu/etd_theses/4406
  
CHARACTERIZATION OF SILVER NANOPARTICLE-INFUSED TISSUE 
ADHESIVE FOR OPHTHALMIC USE 
 
 
 
A Thesis 
Presented to 
The Faculty of the Department of Biomedical, Chemical, and Materials Engineering 
San José State University 
 
 
 
In Partial Fulfillment 
of the Requirements for the Degree 
Master of Science 
 
 
 
by 
William Yee 
December 2013 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2013 
William Yee 
ALL RIGHTS RESERVED 
  
 The Designated Thesis Committee Approves the Thesis Titled 
 
CHARACTERIZATION OF SILVER NANOPARTICLE-INFUSED TISSUE 
ADHESIVE FOR OPHTHALMIC USE 
by 
William Yee 
 
APPROVED FOR THE DEPARTMENT OF BIOMEDICAL, CHEMICAL, AND 
MATERIALS ENGINEERING 
 
SAN JOSÉ STATE UNIVERSITY 
 
December 2013 
 
Dr. Benjamin Hawkins  Department of Biomedical, Chemical, and Materials 
Engineering 
Dr. Guna Selvaduray   Department of Biomedical, Chemical, and Materials 
Engineering 
Dr. Jon Nunes    Roche Molecular Systems 
  
 ABSTRACT 
CHARACTERIZATION OF SILVER NANOPARTICLE-INFUSED TISSUE 
ADHESIVE FOR OPHTHALMIC USE 
by William Yee 
 This research examined if the infusion of silver nanoparticles into a 2-octyl 
cyanoacrylate tissue adhesive alters the antibacterial effectiveness and mechanical 
properties of the adhesive.  Silver nanoparticle size and concentration combinations were 
varied to determine the effects of these factors.  Uniform distribution of the silver 
nanoparticles was achieved before proceeding to testing.  Antibacterial effectiveness of 
the composite adhesive was determined via the Kirby-Bauer disk diffusion susceptibility 
test and by CFU counting.  Doping the adhesive with silver nanoparticles resulted in an 
order of magnitude reduction in bacterial growth.  The greatest antibacterial effect came 
from imbuing 10 μg/mL of 4 nm silver nanoparticles into the tissue adhesive.  Despite the 
noticeable reduction of bacterial growth for the doped adhesives, the difference among 
the varying silver nanoparticle size and concentration combinations was minimal. 
 The breaking strength of the adhesive increased when silver nanoparticles were 
added.  The adhesive strength of the composite adhesive attached to an incised porcine 
sclera was also greater than the unaltered adhesive.  The greatest breaking load and 
adhesive force was the 10 μg/mL of 10 nm silver nanoparticle-doped adhesive.  The 
increased mechanical strength of the doped adhesive expands the possible applications of 
treatment on different areas of the body.
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CHAPTER ONE 
INTRODUCTION 
 The repair of wounds occurring from traumatic injuries and surgical procedures 
can be addressed by several wound closing methods.  Some notable wound closing 
methods are mechanical fasteners, such as sutures, wires, and staples [1].  As with all 
medical treatments and tools, there is constant research and development of safer and 
more efficient ways of treating the ailment.  Thus, the development and application of 
tissue adhesives became an alternative to conventional mechanical fasteners.  These 
tissue adhesives needed to demonstrate comparable mechanical properties as mechanical 
fasteners and also prove to be an antimicrobial agent. 
1.1 History 
1.1.1 History of Tissue Adhesives 
Tissue adhesives have been developed and applied since the 19th century [2].  At 
that time, methyl-2-cyanoacrylate was the first tissue adhesive used for surgical 
application.  In 1909, fibrin was first applied as a hemostatic agent [3].  Fibrinogen was 
then used as an adhesive in 1940 and later was developed into a biologic glue in 1944 [3].  
The initial work on modern cyanoacrylates in 1949 greatly advanced the field of tissue 
adhesives, which then led to the characterization of the adhesive properties of modern 
cyanoacrylate in 1959 [3].  The research and progress on cyanoacrylates allowed the 
adhesive to become clinically used in ophthalmic applications in 1963 and for tympanic 
membrane repair in 1965 [3,4].   In addition to the use of cyanoacrylate in clinical 
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settings, this adhesive was used heavily during the Vietnam War [1].  Cyanoacrylate 
allowed soldiers to quickly seal their wounds and ultimately aided in recovery. 
In 1964, a gelatin-resorcinol-formol adhesive was created and tested and led to its 
application in treating aortic dissections in 1977 [3].  This clinical application was the 
first of its kind and was applied to the most important artery in the human body, which 
distributes oxygenated blood to all tissue.  Gelatin-resorcinol-formol was a good adhesive 
that also improved hemostasis; however, this material did not promote wound healing [3].  
The next major introduction to the tissue adhesive field was the United States Food and 
Drug Administration’s (FDA) approval of a synthetic skin adhesive called Dermabond® 
in 1998 [1].  Chemically designated as 2-octyl-cyanoacrylate, Dermabond® has been 
widely accepted by surgeons and physicians for use in cosmetic surgery and in the 
emergency room [1].  Dermabond® has been used to treat small lacerations and wounds 
in a variety of areas on the body.  The FDA approval and success of Dermabond® 
spawned the development of other synthetic tissue adhesives, using different chemical 
formulations, and also the discovery of further uses for natural adhesives.  Despite some 
“off-label” use of certain tissue adhesives, the range of applications of modern adhesives 
has been expanded to almost every tissue in the body.  This range of applications includes 
nerve anastomosis, bone fixation, and corneal wound repair among many others [1].  
Along with sealing various wounds, tissue adhesives also prevent infection.  The addition 
of an antimicrobial agent, such as parabens or silver nanoparticles, to tissue adhesives has 
been investigated.  Silver nanoparticles are a promising antimicrobial agent that has 
recently been heavily examined. 
3 
 
1.1.2 History of Silver Nanoparticles 
For thousands of years, silver has been widely used for various functions, such as 
utensils, dental alloys, and photography.  Hippocrates, the father of modern medicine, 
believed silver had anti-disease and healing properties and noted it as a treatment for 
ulcers [5].  In 1884, the first documented medical use of silver recorded 1% silver nitrate 
as an eye treatment for neonatal conjunctivitis [5].  For serious burn wounds, topically 
applied silver sulfadiazine cream became the standard antibacterial treatment; its 
effectiveness aids in its prevalent usage today [5].  Until antibiotics were developed, 
silver compounds were major combatants of wound infection in World War I [5].   
As antibiotics replaced silver compounds as the main antibacterial agent, silver 
was not used as heavily in medical applications until the advent of modern science and 
technology.  The next major milestone for silver was the engineering of silver 
nanoparticles.  These nanoparticles have multiple functions and have been used in 
various consumer products such as water purifiers, laundry detergents, and textiles [5].  
Extensive research and development has been done to create marketable medical 
products that utilize the antimicrobial properties of silver nanoparticles in applications 
such as wound dressings, surgical instruments, and contraceptive devices [5]. 
1.2 Significance 
1.2.1 Safety of Tissue Adhesives 
Tissue adhesives offer many safety benefits over the use of sutures, wires, and 
staples.    Mechanical fasteners are inherently invasive and pose potential damage to 
tissue.  Not only do sutures and the like inflict trauma on a patient’s operated tissue, but 
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there is also the risk of needlestick injury to the surgeon or operating room personnel 
[1,6,7].  Suture areas can also be a site for infection and inflammation, which will lead to 
more complications and require additional treatment [6].  After operations, sutures and 
other fasteners have a tendency to loosen and possibly break, which entails extra 
treatment to fix these problems [1].  Tissue adhesives reduce or eliminate the risk of the 
aforementioned safety hazards.  Tissue adhesives also provide a less traumatic closure, a 
reduction of blood loss by the patient, no suture removal, and less pain compared to 
mechanical fasteners [1]. 
Despite some of the safety risks associated with mechanical fasteners, fasteners 
are safer in some aspects than certain tissue adhesives.  If the thrombin and fibrinogen in 
fibrin glues that were obtained from human blood were not properly screened, they can 
carry human viruses and other diseases [1,4].  In contrast, mechanical fasteners do not 
carry the risk of transmitting diseases and viruses. 
1.2.2 Safety of Silver Nanoparticles 
 A nanoparticle has at least one dimension that ranges between 1 and 100 nm.  
Nanoparticles possess an extra-large surface area to volume ratio, which is one of the 
reasons why nanoparticles display distinct physiochemical and biological properties.  The 
extra-large surface area to volume ratio of silver nanoparticles imbues unique 
antimicrobial interactions with bacteria and viruses [5]. 
There is strong research evidence that supports the safety of silver nanoparticles; 
however, a small fraction of research has shown that silver nanoparticles are potentially 
cytotoxic.  Chen and Schluesener point out that silver nanoparticles facilitate the creation 
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of free radicals and reactive oxygen species (ROS) [5].  An over accumulation of ROS 
can elicit an inflammatory response [5].  Long-term occupational exposure can also lead 
to argyria, which is the irreversible bluish-grey pigmentation of the skin and even the 
eyes [5,8].  Despite these relevant toxicological implications, most of the research data 
that support silver nanoparticle cytotoxicity has been carried out by in vitro experiments.  
However, cells may behave differently when they are under in vivo conditions. 
1.2.3 Technical Importance of Tissue Adhesives 
 Tissue adhesives are highly versatile and can be used in various applications.  
They are easy to use, fast to apply, do not require removal, and provide sufficient seal 
quality and strength [1].  Alternatively, mechanical fasteners do pose some technical 
disadvantages.  Sutures, staples, and wires are not suitable for more complicated 
procedures, such as sealing leaks of bodily fluids and air in blood vessels and tissues [1].  
Also, there are some areas of the body that are not easily accessible for the application of 
fasteners; thus, the accuracy of positioning the fasteners will be compromised.  
Successful suturing involves acquired skill that only comes with talent and practice [6].  
Different suturing skill levels influence the time and success of the operation. 
 Compared to mechanical methods, tissue adhesives are aesthetically pleasing and 
the preferred choice for plastic surgeons performing cosmetic surgeries [1].  For ocular 
surgeries, suturing corneas often produces asymmetrical healing which results in a 
regular or an irregular astigmatism [6].  Treating this astigmatism would require more 
complicated surgery or a pair of corrective spectacles. 
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Mechanical fasteners have clear benefits in certain applications in the body.  For 
deep tissue wounds and lacerations, the use of deep support sutures promote the healing 
process and provide more than adequate mechanical strength to join two tissues together 
[1].  Some wounds and lacerations are large and wide, requiring fasteners instead of 
tissue adhesives because of the possibility that the wound reopens and takes a longer time 
to heal.  Mechanical fasteners can also complement tissue adhesives in appropriate 
situations by assisting with the healing process.  In the end, the suitable treatment is 
dependent on the type of wound and the doctor’s preference of treatment. 
1.2.4 Technical Importance of Silver Nanoparticles 
 When compared to their antibiotic counterparts, silver nanoparticles are highly 
effective against organisms that have developed a resistance to multiple drugs [8].  
Additionally, these nanoparticles have a multilevel antibacterial effect on cells, which 
allows the silver to interact with organisms and reduce their chance of developing 
resistance to treatment [8].  Silver nanoparticles are bactericidal because they bind to the 
bacteria’s cell wall, alter their cytoplasmic DNA and proteins, and modify the enzymes 
involved in essential cellular processes [8].  Furthermore, latest research has found that 
silver nanoparticles possess anti-inflammatory properties that might be due to the 
reduction of cytokine release and the decrease infiltration of mast cells and lymphocytes 
[8]. 
1.2.5 Economic Relevance of Tissue Adhesives 
There are more than 12 million procedures done annually throughout the world 
that require the use of nylon sutures to close ocular wounds alone [6].  Since the eyes are 
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commonly operated on, it is safe to say that there are many more millions of procedures 
that require wound closure.  Non-dissolvable mechanical fasteners require removal by the 
doctor.  Trauma occurs and the opportunity for infection is present every time sutures are 
removed [6].  The need for patients to come back to the doctors to have mechanical 
fasteners removed and the chance that further complications might arise requiring 
subsequent treatments is highly undesirable and ultimately uneconomical.  Visiting the 
doctor for follow-up medical attention will incur additional costs to patients and 
potentially the government via Medicare or Medicaid.  Alternatively, tissue adhesives 
eliminate the need for mechanical fastener removal and the possibility of additional 
trauma and infection.  From a doctor’s perspective, adhesives will reduce the surgery 
time, allowing the doctor to operate on more patients and ultimately earn more money. 
The large volume of procedures that require wound closure presents a viable 
market for tissue adhesives.  While mechanical fasteners remain the most common 
method for wound closure, recent advances are making tissue adhesives a viable 
alternative and potential replacement wound closure technique.  Hence, there is a 
growing amount of research and development for the application of various natural, 
synthetic, semisynthetic, and biomimetic tissue adhesives [1].  Despite the fact that some 
adhesives are more expensive than typical sutures, the favorable properties and the 
development of more commercial adhesives establishes tissue adhesives as an 
economical option for wound care management. 
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1.2.6 Economic Relevance of Silver Nanoparticles 
 The commercial nanotechnology industry is expected to reach $3 trillion by 2015 
[9].  Because nanomaterials have been incorporated in many sectors of society, there is 
no doubt that there is a massive economic impact.  Silver nanoparticles are the most 
commercialized nanomaterial in the medical field [5].  Current and future research of 
silver nanoparticles will further expand the market for medical products containing the 
effective antimicrobial property of the nanoparticle. 
1.3 Potential Areas of Research 
Injury can occur at every part of the body, which necessitates doctors to care for 
them with different treatments and tools.  The past century featured many advances in the 
field of wound care management, as evidenced by the various fields utilizing tissue 
adhesives.  Some of these fields include hematology, gynecology, neurology, cardiology, 
urology, dentistry, dermatology, and ophthalmology [1].  Even though all these fields 
vary in the type of procedures performed, repairing wounds requires a tissue adhesive 
that possesses ideal properties. 
First, the tissue adhesive needs to hold together two sides of tissue until the body 
can properly heal the wound [1].  Second, the adhesive should be able to polymerize in a 
moist environment within a reasonable curing time [1,2].  Third, the adhesive must be 
steadily metabolized by the surrounding tissue without generating an inflammatory 
response or be a site for infection [1,6].  Lastly, the adhesive should not deform the tissue 
and cause discomfort to the patient postoperatively [1,2].  All of these features are what 
all tissue adhesives should essentially share in common. 
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Silver nanoparticles must have low systemic toxicity and be effective as a 
bactericide.  There has been minimal research on the infusion of silver nanoparticles into 
a tissue adhesive.  To the author’s knowledge, there has been no research on the 
application of silver nanoparticle-infused tissue adhesives for ophthalmic use.  The eyes 
are important organs of the body and are subjected to various procedures. As a result, the 
eyes have the potential to be a site for infection and inflammation. 
1.4 Focus 
This research focused on the infusion of silver nanoparticles in tissue adhesives 
for ophthalmic use.  The effectiveness of the antimicrobial property of silver 
nanoparticles mixed with the adhesive was studied.  Furthermore, the mixture adhesive 
was examined to determine if the silver nanoparticles alter the mechanical properties of 
the adhesive. 
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 Overview 
Tissue adhesives offer many benefits in repairing traumatic and surgical wounds.  
To be effective, tissue adhesives need to be nontoxic, have a rapid curing time, and 
possess favorable mechanical properties.  The mechanical properties of tissue adhesives 
changes when silver nanoparticles are infused into the adhesive.  Furthermore, the 
antibacterial efficacy is affected when silver nanoparticles are infused into a polymer.  
This chapter discusses the previous research performed that evaluates the mechanical and 
antibacterial properties of the infusion of silver nanoparticles into a polymer.  Despite the 
research conducted in the addition of silver nanoparticles to a polymer, there are no 
studies on the infusion of silver nanoparticles into a tissue adhesive for ophthalmic use.  
This literature review investigates the areas needed to develop this tissue adhesive for the 
use in the eye. 
2.2 Tissue Adhesives for Ophthalmic Use 
2.2.1 2-Octyl Cyanoacrylate 
 Multiple types of tissue adhesives have been tested for various ophthalmic 
wounds and conditions.  A common adhesive is 2-octyl cyanoacrylate.  Ritterband et al. 
used this adhesive to seal clear cataract wounds.  Due to the influx of surface bacteria 
present in extraocular fluid before wound epithelialization, a 3.0 mm clear corneal 
incision is a possible site of infection and inflammation [10].  Ritterband et al. studied the 
effectiveness of 2-octyl cyanoacrylate (Liquid Bandage™, Johnson & Johnson) in sealing 
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a clear corneal incision by testing the influx of India ink with varying intraocular 
pressures and manual wound manipulations.  India ink was used because the opaque fluid 
particle size is comparable to the size of bacteria [10].  The dynamic flow of fluid at 
varying intraocular pressures and wound manipulations attempts to simulate the 
unpredictability of the eye environment. 
 This study by Ritterband and his group had two phases to prove the sealing 
efficacy of the adhesive.  In the first phase, the researchers created corneal incisions in 
seven human cadaver eyes to test the influx of India ink by adjusting the intraocular 
pressure from 4 mmHg to 22 mmHg and manipulating the wound by manually applying 
70 mmHg of pressure to the wound [10].  The second phase consisted of the same 
experiment as phase one, but this time the corneal incisions were sealed with 2-octyl 
cyanoacrylate.  For phase one, one eye demonstrated the ingress of fluid when the 
intraocular pressure was less than 5 mmHg, while India ink leaked into the anterior 
chamber of the other eyes when more than 70 mmHg of manual pressure was applied on 
the incision [10].  In contrast, all of the human eyes with the 2-octyl cyanoacrylate sealed 
corneal incisions did not experience any influx of India ink when the same tests were 
applied. 
 Meskin et al. confirmed the sealing efficacy of the same 2-octyl cyanoacrylate 
tissue adhesive used in the Ritterband et al. study.  Instead of using human cadaver eyes, 
the Meskin et al. study was assessed in vivo in 51 eyes of 51 cataract surgery patients.  
After the cataract surgery and before the application of the adhesive, all incisions were 
hydrated with a balanced saline solution and were examined for leakage by applying 
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gentle pressure to the wound with a cellulose sponge.  Out of the 51 eyes, seven of the 
eyes displayed leakage [11].  There was no leakage present in all 51 eyes when the 
adhesive was applied. 
 In other research, Duffy et al. created and tested a scaffold-enhanced 2-octyl 
cyanoacrylate adhesive composite that was intended for correcting strabismus.  
Strabismus is the misalignment of the eyes due to the lack of synchronization between the 
extraocular muscles, which results in the inability of both eyes to focus on the same point 
[12].  Duffy et al. evaluated the breaking loads of extraocular muscles to ocular tissues or 
other extraocular muscles using the scaffold-enhanced adhesive.  A scaffold was added to 
the 2-octyl cyanoacrylate adhesive because the scaffold increased the breaking load of the 
adhesive [7].  The scaffolds used were made out of either poly(L-lactic-co-glycolic acid) 
(PLGA) or porcine small intestine submucosa.  The 2-octyl cyanoacrylate used was 
Dermabond®.  As a reference, Duffy and his group analyzed the breaking loads of an 
unoperated eye and its extraocular muscles.  Next was the testing of the breaking loads 
between the ocular tissues and extraocular muscles with 2-octyl cyanoacrylate alone and 
also with the scaffold-enhanced composite adhesive.  The breaking load was found to be 
greatest with the composite adhesive, while the breaking load of 2-ocytl cyanoacrylate 
was the next highest and the unoperated eye was the lowest [7].  Further details of this 
study are discussed in the Section 2.10. 
2.2.2 Fibrin 
 Fibrin is another common tissue adhesive for ophthalmic use.  Banitt et al. 
compared the sealing ability of a fibrin adhesive (Tisseel®, Baxter Healthcare 
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Corporation), n-butyl-2-cyanoacrylate (Histoacryl®, TissueSeal) adhesive, and 10-0 
nylon sutures on clear corneal incisions.  The research focused on the relation between 
incision size and the intraocular pressure when leakage occurred after an adhesive or 
suture was applied.  Using porcine eyes, Banitt et al. gradually increased the intraocular 
pressure from 20 mmHg to 700 mmHg.  The results of the study showed that regardless 
of the incision size, the n-butyl-2-cyanoacrylate adhesive was far superior in sealing clear 
corneal incisions because of the high pressures the adhesive can withstand before liquid 
seeps in [13].  Fibrin was generally the second best adhesive when sealing clear corneal 
incisions; however, as the incision size increased, the sealed corneas that used 10-0 nylon 
sutures were able to withstand a similar intraocular pressure as their fibrin counterparts.  
The intraocular pressure that the n-butyl-2-cyanoacrylate adhesive can tolerate before the 
corneal incision leaked was about two to three times more than the intraocular pressure 
that the fibrin adhesive or 10-0 nylon sutures can handle. 
Fibrin is also used as a tissue adhesive to secure a lamellar graft and to attach 
amniotic tissue to a bare scleral wound.  Kaufman et al. used a fibrin adhesive (Tisseel® 
VH Fibrin Sealant, Baxter Healthcare Corporation) to fasten a lamellar graft and found 
that all five of the patients’ lamellar grafts were healed and transparent.  In addition, the 
amniotic tissue was affixed securely onto the bare sclera of a patient.  Based on the 
successful results of the study, Kaufman et al. concluded that the adhesive should be 
effective in sealing LASIK corneal flaps, conjunctival grafts, and clear corneal incisions 
[4].  However, in agreement with Banitt et al., Kaufman and his colleagues noted the 
lengthy 20 min preparation time of mixing the fibrin ingredients and the high cost of the 
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adhesive ($121 for 2 mL) compared to sutures ($15) [4,13].  Also, if not properly 
screened, fibrin adhesives obtained from human blood can carry viruses and other 
diseases [1,4]. 
2.2.3 Hydrogels 
 Hovanesian tested the sealing effectiveness of a polyethylene glycol hydrogel 
adhesive (I-ZIP® Ocular Bandage, I-Therapeutix).  Clear corneal incisions were made on 
24 human cadaver eyes and were tested for India ink leakage under low pressure 
conditions and with external wound manipulations.  Twelve eyes were treated with the 
hydrogel adhesive and reported no fluid ingress when the intraocular pressure was at 33 
mmHg, which is similar to the intraocular pressure of an incision during cataract surgery 
[14].  Furthermore, no fluid leakage was observed when there was external manipulation 
of the incision.  The other twelve eyes were set apart as controls.  Nine of the control eyes 
experienced fluid influx with varying intraocular pressures, while eleven of the control 
eyes leaked India ink with external manipulation of the wound [14]. 
 Strehin et al. evaluated the sealing ability of a chondroitin sulfate-polyethylene 
glycol adhesive.  To test the sealing effectiveness of the synthesized adhesive, the 
researchers measured the intraocular pressure when the excised porcine eyes began to 
leak.  The experiment was set up to allow the variation of intraocular pressure with a 
pressure sensor and a 20-gauge needle connected to a syringe pump that was inserted into 
the anterior chamber of the eye [15].  Once the eye was in equilibrium, Strehin and his 
group increased the pumping of fluid into the eye to ensure a non-self-sealing incision 
that aided in demonstrating the functionality of the adhesive.  This experimental setup is 
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exhibited in Figure 1.  Two out of the three adhesive treated eyes maintained wound 
sealing integrity at intraocular pressures greater than 200 mmHg.  One eye experienced 
leakage at 200 mmHg. 
 
Figure 1. Experimental setup that allowed adjustment of intraocular pressure in the 
anterior chamber of the eye.  The intraocular pressure was increased until fluid leaked 
through the incision [15].  (Reprinted from J. Cataract Refractive Surg., 35, I. Strehin, 
W.M. Ambrose, O. Schein, A. Salahuddin and J. Elisseeff, Synthesis and 
characterization of a chondroitin sulfate-polyethylene glycol corneal adhesive, 567-576, 
2009, with permission from Elsevier)  
 
 
2.3 Generating Silver Nanoparticles 
 Silver nanoparticles are synthesized by either the top-down or bottom-up 
techniques [16].  The top-down approach mechanically reduces bulk silver to the 
nanoscale size via laser ablation and lithography [17].  Conversely, the bottom-up 
approach is the dissolution of silver salt into a solvent [16].  The addition of a reducing 
agent and stabilizing agent precipitates formation of silver nanoparticles [16].  The 
bottom-up technique is the preferred and predominant method to synthesize silver 
nanoparticles primarily because the mechanical reduction of the top-down technique 
produces surface imperfections, which impacts the applicability of the silver 
nanoparticles [16,18]. 
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2.3.1 Silver Salt Precursors Used in Silver Nanoparticle Synthesis 
 In the bottom-up method, silver salt precursors are dissolved in a solvent to 
produce ionic silver as part of the synthesis of silver nanoparticles [16].  When compared 
to other silver salt precursors, silver nitrate (AgNO3) is the predominant silver salt 
precursor used in research due to its chemical stability and low cost [16,19].  In a 
scientific literature review conducted by Tolaymat et al., 200 pertinent articles referenced 
the statistics involved with the synthesis of silver nanoparticles.  The percentage of 
certain silver salt precursors used in the scientific literature review in relation to other 
salts is portrayed in Figure 2. 
 
Figure 2. The silver salt precursors used in scientific literature to synthesize silver 
nanoparticles.  Silver nitrate accounted for 83% of the silver salt precursors in the review 
[16].  (Reprinted from Sci. Total Environ., 408, T.M. Tolaymat, A.M. El Badawy, A. 
Genaidy, K.G. Scheckel, T.P. Luxton and M. Suidan, An evidence-based environmental 
perspective of manufactured silver nanoparticle in syntheses and applications: A 
systematic review and critical appraisal of peer-reviewed scientific papers, 999-1006, 
2010, with permission from Elsevier)  
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2.3.2 Solvents Used in Silver Nanoparticle Synthesis 
 In the bottom-up method, organic and inorganic solvents are used to dissolve the 
silver salt precursors as part of the silver nanoparticle synthesis process [16].  Organic 
solvents are heavily used for the production of high particle concentrations with a 
predefined shape and size [20,21].  Due to the low cost and availability of water, it is the 
prime solvent used in the synthesis of silver nanoparticles [16].  Water is used to generate 
stable and mobile silver nanoparticles in an aqueous environment [16].  The number of 
researchers using water as a solvent in comparison to other solvents is shown in Figure 3. 
 
 
Figure 3. The solvents used in scientific literature to synthesize silver nanoparticles.  
Water accounted for about 60% of the solvents in the review.  The diagonal-shaded bars 
depict the solvents used for the synthesis of silver nanoparticles for certain applications 
[16].  (Reprinted from Sci. Total Environ., 408, T.M. Tolaymat, A.M. El Badawy, A. 
Genaidy, K.G. Scheckel, T.P. Luxton and M. Suidan, An evidence-based environmental 
perspective of manufactured silver nanoparticle in syntheses and applications: A 
systematic review and critical appraisal of peer-reviewed scientific papers, 999-1006, 
2010, with permission from Elsevier)  
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2.3.3 Reducing Agents Used in Silver Nanoparticle Synthesis 
 The use of a reducing agent is necessary for the bottom-up approach of 
synthesizing silver nanoparticles.  Reducing agents offer free electrons to reduce the 
silver ions that will eventually form the nanoparticles [16].  These agents can be a 
chemical or biological agent, plant extract, or an irradiation method [16].  Sodium 
borohydride (NaBH4) and sodium citrate are the prevalent reducing agents used to form 
silver nanoparticles, which is shown in Figure 4 of the Tolaymat et al. study.  Sodium 
borohydride is a strong reducing agent that typically generates a narrow range of small, 
uniform particles [16].  To form larger particles, a weaker reducing agent is used such as 
ascorbic acid [22]. 
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Figure 4. The reducing agents used in scientific literature to synthesize silver 
nanoparticles.  Sodium borohydride (NaBH4) and sodium citrate accounted for about 
33% of the reducing agents in the review.  The diagonal-shaded bars depict the reducing 
agents used for the synthesis of silver nanoparticles for certain applications.  The “other” 
category was composed of reducing agents that were rarely used in the literature review 
[16].  (Reprinted from Sci. Total Environ., 408, T.M. Tolaymat, A.M. El Badawy, A. 
Genaidy, K.G. Scheckel, T.P. Luxton and M. Suidan, An evidence-based environmental 
perspective of manufactured silver nanoparticle in syntheses and applications: A 
systematic review and critical appraisal of peer-reviewed scientific papers, 999-1006, 
2010, with permission from Elsevier)  
 
2.3.4 Stabilizing Agents Used in Silver Nanoparticle Synthesis 
 In the bottom-up approach, stabilizing agents are used to control the size of the 
nanoparticle and to prevent nanoparticle agglomeration [16].  According to the research 
of Olenin et al., the aggregation of nanoparticles is due to the high thermodynamic 
instability and extra surface energy on the particle surface [23].  Stabilizing agents can be 
surfactants or polymers containing functional groups [16,23].  The concentration of a 
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stabilizing agent also determines the reactivity, solubility, stability, shape, and size of the 
nanoparticle [24].  The different types of stabilizing agents are illustrated in Figure 5. 
 
Figure 5. The stabilizing agents used in scientific literature to synthesize silver 
nanoparticles.  Sodium citrate accounted for about 27% of the stabilizing agents in the 
review.  The diagonal-shaded bars depict the stabilizing agents used for the synthesis of 
silver nanoparticles for certain applications.  The “other” category was composed of 
stabilizing agents rarely used in the literature review [16].  (Reprinted from Sci. Total 
Environ., 408, T.M. Tolaymat, A.M. El Badawy, A. Genaidy, K.G. Scheckel, T.P. 
Luxton and M. Suidan, An evidence-based environmental perspective of manufactured 
silver nanoparticle in syntheses and applications: A systematic review and critical 
appraisal of peer-reviewed scientific papers, 999-1006, 2010, with permission from 
Elsevier)  
 
2.4 Silver Nanoparticle Size and Concentration 
 In a study performed by Lee and Tsao, they examined the factors that effected 
silver nanoparticle diameter size.  A particle size analyzer was used to measure the silver 
nanoparticle size.  The study used 100 mL of 100 ppm silver nitrate solution as the silver 
salt precursor and mixed it with 1 g of 1-vinyl-2-pyrrolidinone in 100 mL of water at 
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room temperature for 12 h [25].  The researchers found that the silver nanoparticle size 
increased as the concentration of the silver nitrate solution in 1-vinyl-2-pyrrolidinone 
mixture increased [25].  Lee and Tsao recognized that the increase of particle size was the 
result of an agglomeration of silver nanoparticles due to the lack of a stabilizing agent 
when the concentration of the silver aqueous mixture increased [25].  This finding 
supports the research of Olenin et al., which also found that the aggregation of particles 
was prevented by the addition of a stabilizing agent. 
Additionally, the results demonstrated that the silver particle size was notably 
affected by the stirring rate and the silver nitrate/1-vinyl-2-pyrrolidinone (AgNO3/VP) 
mixture concentration ratio [25].  Figure 6 shows that a higher stirring rate means a 
smaller particle size; however, the increased concentration of silver nitrate in the 
AgNO3/VP mixture also means an increase of particle size, regardless of the higher 
stirring rate.  The 300 nm particle size with the higher stirring rate depicted in Figure 6 
cannot be considered a nanoparticle because a nanoparticle is between 1 and 100 nm in 
size [5].  Nevertheless, the study does reveal that a higher stirring rate translates to the 
generation of a smaller particle. 
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Figure 6. The stirring rate affected the particle size under different silver nitrate 
concentrations in 1-vinyl-2-pyrrolidinone solution at 30°C [25].  (Reprinted from J. 
Mater. Sci., 45, W-F. Lee and K-T. Tsao, Effect of silver nanoparticles content on the 
various properties of nanocomposite hydrogels by in situ polymerization, 89-97, 2010, 
with permission from Springer Science and Business Media)  
 
The AgNO3/VP mixture weight ratio was also an important factor that was 
considered to produce appropriate sized silver nanoparticles.  Figure 7 shows that silver 
particle size was affected by different silver nitrate concentrations under varying 
AgNO3/VP weight ratios.  With a lower AgNO3/VP weight ratio, the silver particle size 
decreased to become equal or less than 100 nm, which is in the size range of a 
nanoparticle [5,25].  Lee and Tsao concluded that when the AgNO3/VP weight ratio was 
lowered to 1/10, the extra 1-vinyl-2-pyrrolidinone chelated the dispersible silver ions to 
form the smallest silver particle diameter size at 72 nm [25]. 
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Figure 7. The mean silver particle size versus various AgNO3/VP concentration weight 
ratios with a stirring rate of 300 rpm at 30°C and was reduced by ultraviolet irradiation.  
When the AgNO3/VP weight ratio was lowered to 1/10, the smallest particle size can be 
formed to be 72 nm [25].  (Reprinted from J. Mater. Sci., 45, W-F. Lee and K-T. Tsao, 
Effect of silver nanoparticles content on the various properties of nanocomposite 
hydrogels by in situ polymerization, 89-97, 2010, with permission from Springer Science 
and Business Media)  
 
 The review conducted by Tolaymat’s group concluded that researchers preferred 
to use smaller sized particles, especially between 0 and 10 nm [16].  Different 
nanoparticle sizes were chosen based on what was more suitable for the application.  In 
Figure 8, the nanoparticle size of 0-10 nm is shown to be used in 45% of general 
applications, which is almost double the percentage of the next most commonly used 
particle size of 11-20 nm [16]. 
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Figure 8. The size of synthesized silver nanoparticles used in scientific literature.  The 
range of 0 to 10 nm accounted for about 45% of the nanoparticle sizes in the review.  The 
diagonal-shaded bars depict the silver nanoparticle sizes used in specific applications 
[16].  (Reprinted from Sci. Total Environ., 408, T.M. Tolaymat, A.M. El Badawy, A. 
Genaidy, K.G. Scheckel, T.P. Luxton and M. Suidan, An evidence-based environmental 
perspective of manufactured silver nanoparticle in syntheses and applications: A 
systematic review and critical appraisal of peer-reviewed scientific papers, 999-1006, 
2010, with permission from Elsevier)  
 
2.5 Silver Nanoparticle Shape 
 Silver nanoparticles are formed into many different shapes such as plates, rods, 
spheres, triangles, and hexagons [16,26].  Sadeghi et al. studied the antibacterial 
effectiveness of a few of these various shapes.  They used N-N’-dimethyl formamide to 
reduce silver nitrate and poly(N-vinyl-2-pyrrolidone) to stabilize the mixture to produce 
uniform, non-agglomerated particles [26,27].  The results showed that the antibacterial 
efficacy of silver nanoparticles was highly dependent on the amount of surface area of the 
particle that the bacteria can interact with [26].  Table 1 displays the surface area of the 
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nanosilver shapes examined by Sadeghi’s group, which includes hexagonal nanoparticles, 
nanorods, and nanoplates.  Table 2 presents the growth inhibition rates of the nanosilver 
shapes against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli).  This 
table supports the study’s conclusion that a larger nanoparticle surface area increases the 
antibacterial efficacy. 
Table 1. The surface area of the examined nanosilver shapes [26].  (Reprinted from 
Adv. Powder Technol., 23, B. Sadeghi, F.S. Garmaroudi, M. Hashemi, H.R. Nezhad, 
A. Nasrollahi, S. Ardalan and S. Ardalan, Comparison of the anti-bacterial activity 
on the nanosilver shapes: Nanoparticles, nanorods and nanoplates, 22-26, 2012, with 
permission from Elsevier)  
 
Nanosilver Shapes Surface Area (m2/g)
Silver Hexagonal Nanoparticles 17.8
Silver Nanorods 38.8
Silver Nanoplates 121.1  
 
 
Table 2. The growth inhibition rates of the nanosilver shapes against S. aureus and E. 
coli.  Note that the growth inhibition rates of all nanosilver shapes were high, which 
means that regardless of the shape chosen, the antibacterial property of nanosilver 
was effective [26].  (Reprinted from Adv. Powder Technol., 23, B. Sadeghi, F.S. 
Garmaroudi, M. Hashemi, H.R. Nezhad, A. Nasrollahi, S. Ardalan and S. Ardalan, 
Comparison of the anti-bacterial activity on the nanosilver shapes: Nanoparticles, 
nanorods and nanoplates, 22-26, 2012, with permission from Elsevier)  
 
 
 
 
2.6 Infusing Silver Nanoparticles into a Polymer 
 The incorporation of silver nanoparticles into a polymer can be done by a few 
approaches, such as in situ, ex situ, melt processing, and sonication [25,28,29].  The ex 
Sample (10 ppm)
S. aureus E. coli
Silver Hexagonal Nanoparticles 95.5 92.5
Silver Nanorods 97.3 93.4
Silver Nanoplates 98.5 94.2
Growth Inhibition Rate (%)
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situ approach is when the silver nanoparticles are generated via soft-chemistry routes and 
then spread throughout a polymer matrix [25].  The in situ approach is when the silver 
nanoparticles are produced inside a polymer matrix via decomposition or chemical 
reduction of the silver salt precursor dissolved into the polymer [25].  The melt 
processing method is when the silver nanoparticles and polymer are mixed together at 
high temperatures while being spun at a constant speed [30].  For the melting process, 
Radheshkumar and Münstedt produced the melted compound with an internal mixer at 
230°C while rotating at 60 rpm for 7 min [30].  Sonication uses ultrasonic energy to 
evenly disperse nanoparticles within a liquid or polymer [29].  The two methods of 
sonication are direct and indirect sonication.  Direct sonication is the production of 
ultrasonic waves in the polymer by immersing an ultrasonic probe within the polymer 
suspension [29].  Indirect sonication is the propagation of ultrasonic waves through a 
liquid bath surrounding the nanoparticle-doped polymer sample container [29]. 
 The in situ method is a commonly used technique in the scientific literature to 
generate a polymer containing silver nanoparticles.  Lee and Tsao applied this method to 
produce a silver nanoparticle-infused hydrogel that was used as a bioadhesive for hard 
and soft tissue applications [25].  The first step of creating the silver nanoparticle-infused 
hydrogel was the addition of a 1-vinyl-2-pyrrolidinone/silver ion precursor solution into a 
monomer solution containing 1 mol% of ethylene glycol dimethacrylate (EGDMA) and 1 
mol% of 2,2-diethoxyacetophenone (DEAP) [25].  EGDMA was a crosslinker and DEAP 
was a photoinitiator [25].  Lastly, the mixture was polymerized and reduced 
simultaneously by exposing the solution to 600 W of ultraviolet radiation for 2 h [25].  
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 Deka et al. used an in situ polymerization technique to create a silver 
nanoparticle-infused polyurethane [31].  A silver nitrate solution was reduced by N,N’-
dimethylformamide (DMF) and was added to a hyperbranched polyurethane matrix at 
room temperature [31].  Subsequently, the mixture was vigorously stirred for 2.5 h [31].  
The researchers found that the nature of the atmosphere has no effect on the formation of 
the silver nanoparticle-infused polyurethane [31].  Uniform distribution of the silver 
nanoparticles in the polyurethane was confirmed via transmission electron microscopy 
(TEM). 
 Zhou et al. used the in situ approach to synthesize a silver nanoparticle-doped 
gelatin and carboxymethyl chitosan (CM-chitosan) hydrogel [32].  These generated 
hydrogels proved to be stable and have homogenous distribution of the silver 
nanoparticles in the polymer matrix [32].  The first step in preparing the infused 
hydrogels was dissolving silver nitrate powder into deionized water.  Next, a 10 wt% 
total concentration of a 2:3 weight ratio of gelatin and CM-chitosan powders were mixed 
into the silver solution at 50°C with an ARE-310 hybrid mixer for 20 min to produce a 
homogenous polymer solution [32].  Zhou et al. used 30 kGy of gamma radiation at 
ambient temperature located in a 60Co facility as a crosslinker and reducing agent [32]. 
 Lin et al. examined the dispersion of silver nanoparticles with sonication.  They 
observed the dispersion of the nanoparticles with a field emission scanning electron 
microscope (FE-SEM).  The ultrasonic energy delivered at various power intensities was 
sufficient in dispersing the nanoparticles.  Greater ultrasonic power delivered to 
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agglomerated silver nanoparticles provided better dispersion [33].  However, greater 
ultrasonic energy also signified that more heat was imparted to the sample. 
2.7 Bacteria Culturing and Types of Bacteria 
 Two of the most common bacteria used in determining the antibacterial properties 
of silver nanoparticles are S. aureus and E. coli [26,28,31].  Despite multiple methods of 
culturing bacteria, there are some commonalities in the bacterial culturing process.  Zhou 
et al. cultivated their E. coli bacterial culture at 37°C in a sterilized Luria-Bertani (LB) 
broth [32].  The mixture was placed into a rotary shaker and shaken at 150 rpm for 16 h 
[32].  Lee and Tsao also used a similar preparation method for their bacterial culture.  E. 
coli was preserved on LB agar, which was composed of a LB medium and 15 g/L of agar 
[25].  The bacterial cells were added to 100 mL of LB medium and were placed into a 
37°C incubator to be shaken at 170 rpm for 12 to 16 h [25].  Likewise, Deka et al. 
incubated S. aureus and E. coli bacteria at 37°C for 24 h by adding it to a Mueller Hinton 
broth [31]. 
2.8 Antibacterial Efficacy of Silver Nanoparticle-Infused Polymers 
2.8.1 Kirby-Bauer Disk Diffusion Susceptibility Technique 
 Zhou et al. used the Kirby-Bauer disk diffusion susceptibility test to assess the 
antibacterial performance of the silver nanoparticle-infused hydrogel [32].  They first 
dispensed 50 μL of bacteria medium containing a concentration of 106 colony-forming 
units per milliliter (CFU/mL) of E. coli onto an agar plate.  A disk-shaped sample of the 
silver nanoparticle-infused hydrogel was then placed on the agar plate and incubated at 
37°C for 12 h [32].  After the incubation period, the diameter of the bacterial growth 
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inhibition halo around each composite sample was measured to determine the 
antibacterial efficacy of the composite [32].  A larger inhibition halo diameter signified 
the bacteria having a larger susceptibility to the antibacterial composite. 
 Sadeghi et al. also used the Kirby-Bauer technique by placing nanosilver-filled 
disks onto separate S. aureus and E. coli-filled agar plates and incubated the sample 
mediums for 24 h at 37°C [26].  During the incubation period, the samples were supposed 
to absorb water from the agar plate while the antibacterial silver diffused into the 
surrounding agar [26,34].  The diameters of the inhibition halos were measured to detect 
the effectiveness of the antibacterial samples. 
2.8.2 Measurement of the Colony-Forming Unit 
 Lee and Tsao assessed the antibacterial activity of their silver nanoparticle-
infused hydrogel by adding the bacterial culture to the composite samples in sterile water 
and incubated it in a 37°C shaker [25].  The samples were removed in 20 min intervals 
between 20 and 120 min [25].  This solution was diluted between 103 and 105 fold with a 
0.85 % saline solution and was mixed with LB broth [25].  After gentle shaking of the 
mixture, the contents remained untouched until solidified.  Following two days of 
incubation at 37°C, the developed colonies were counted to determine their viability in 
the antibacterial environment [25].  The viability was represented by the log of the 
colony-forming unit per milliliter [25].  Figure 9 illustrates the deactivation of E. coli by 
comparing the change in viability during the interval incubation times.  The deactivation 
of the bacteria was greatest when the silver nanoparticle concentration was the highest 
[25]. 
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Figure 9. The deactivation of E. coli in relation to the interval incubation times of the 
composite materials.  APEAg is the sample code prefix, while the subsequent sample 
numbers denote the multiples of 55.6 ppm silver nanoparticles in the sample.  The 
viability corresponds to the log of the colony-forming unit per milliliter [25].  (Reprinted 
from J. Mater. Sci., 45, W-F. Lee and K-T. Tsao, Effect of silver nanoparticles content on 
the various properties of nanocomposite hydrogels by in situ polymerization, 89-97, 
2010, with permission from Springer Science and Business Media)  
 
 Sadeghi et al. also measured the colony-forming unit in their study.  A mixture of 
nanosilver and 1.5 x 105 colony-forming units of S. aureus and E. coli were cultured at 
37°C in a shaking incubator for 12 h [26].  This mixture was then seeded onto a LB agar 
plate and incubated for 24 h at 37°C [26].  After the incubation time, the colony-forming 
units were counted.  The counted number was used in Equation 1 to calculate the 
antibacterial efficacy of the nanosilver samples. 
ABE (%) = [(Vc – Vt) / Vc] * 100     Equation 1 
31 
 
Vc and Vt symbolize the number of viable bacterial colonies of the silver nitrate blank 
control and nanosilver samples, respectively [26].  Figure 10 and Figure 11 shows the 
growth inhibition curves of E. coli and S. aureus in LB medium with different silver 
concentrations, respectively. 
 
Figure 10. The growth inhibition curves of E. coli in LB medium with different silver 
concentrations.  Note the effectiveness of the nanosilver samples in decreasing the 
number of bacterial colonies over time.  Ag-NPs, Ag-NRds, and Ag-NPls denote silver 
nanoparticles, silver nanorods, and silver nanoplates, respectively [26].  (Reprinted from 
Adv. Powder Technol., 23, B. Sadeghi, F.S. Garmaroudi, M. Hashemi, H.R. Nezhad, A. 
Nasrollahi, S. Ardalan and S. Ardalan, Comparison of the anti-bacterial activity on the 
nanosilver shapes: Nanoparticles, nanorods and nanoplates, 22-26, 2012, with 
permission from Elsevier)  
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Figure 11. The growth inhibition curves of S. aureus in LB medium with different silver 
concentrations.  Note the effectiveness of the nanosilver samples in decreasing the 
number of bacterial colonies over time.  Ag-NPs, Ag-NRds, and Ag-NPls denote silver 
nanoparticles, silver nanorods, and silver nanoplates, respectively [26].  (Reprinted from 
Adv. Powder Technol., 23, B. Sadeghi, F.S. Garmaroudi, M. Hashemi, H.R. Nezhad, A. 
Nasrollahi, S. Ardalan and S. Ardalan, Comparison of the anti-bacterial activity on the 
nanosilver shapes: Nanoparticles, nanorods and nanoplates, 22-26, 2012, with 
permission from Elsevier)  
 
Liu et al. embedded three average sizes of silver nanoparticles within 
polyurethane.  The average sizes were 3, 6, and 25 nm.  They performed a CFU count test 
and found that a smaller average silver nanoparticle size demonstrated the greatest 
antibacterial effect [35].  As the nanoparticle size increased, the antibacterial 
effectiveness decreased.  The smaller silver nanoparticles were characterized by a larger 
surface area to volume ratio to interact with the bacteria and impart its bactericidal 
property [35].  Liu et al. also found that increasing the silver nanoparticle concentration 
increased the antibacterial efficacy of the polyurethane. 
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2.9 Tensile Strength 
 The tensile strength of a material is typically tested by a universal testing machine 
[7,31].  Deka et al. created polymers that contained 1, 2.5, and 5 wt% of silver 
nanoparticles to see if the silver nanoparticles influenced the tensile strength of the 
polyurethane [31].  The group used a universal testing machine that had a 10 kN load cell 
and a 50 mm/min crosshead speed to test the tensile strength [31].  They found that the 
increased concentration of the silver nanoparticles increased the tensile strength of the 
composite material.  The values obtained from the universal testing machine are 
displayed in Table 3.  In Figure 12, a stress-strain curve depicts the improved tensile 
strength of the polyurethane when mixed with silver nanoparticles.  Deka et al. suggested 
that the improved tensile strength was due to the increased interactions of the silver 
nanoparticles with the hard segment of the polyurethane matrix [31]. 
Table 3. The tensile strength of each polyurethane sample containing different 
concentrations of silver nanoparticles.  Tensile strengths were measured and 
expressed as the mean ± standard deviation.  HBPU stands for hyperbranched 
polyurethane.  HBPUAg + number stands for a hyperbranched polyurethane 
containing a weight percent of silver nanoparticles.  LPU stands for linear 
polyurethane.  LPUAg + number stands for a linear polyurethane containing a weight 
percent of silver nanoparticles [31].  (Reprinted from Polym. Degrad. Stab., 95, H. 
Deka, N. Karak, R.D. Kalita and A.K. Buragohain, Bio-based thermostable, 
biodegradable and biocompatible hyperbranched polyurethane/Ag nanocomposites 
with antimicrobial activity, 1509-1517, 2010, with permission from Elsevier)  
 
 
 
HBPU HBPU Ag1 HBPU Ag2.5 HBPU Ag5 LPU LPU Ag2.5
Tensile 
Strength 
(MPa) 6.80 ± 1.2 8.13 ± 1.4 9.42 ± 1.1 11.51 ± 1.5 5.31 ± 0.95 9.60 ± 1.1
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Figure 12. A stress-strain curve depicting the increased tensile strength of the 
polyurethane when mixed with silver nanoparticles [31].  (Reprinted from Polym. 
Degrad. Stab., 95, H. Deka, N. Karak, R.D. Kalita and A.K. Buragohain, Bio-based 
thermostable, biodegradable and biocompatible hyperbranched polyurethane/Ag 
nanocomposites with antimicrobial activity, 1509-1517, 2010, with permission from 
Elsevier)  
 
 
 Liu et al. measured the tensile strength of their silver nanoparticle-embedded 
polyurethane.  Their specimens were cut to a length and width of 20 mm by 1 mm and 
tested on a universal testing machine.  The specimens were pulled at 1 mm/min until 
fracturing.  The tensile strength noticeably increased for the polyurethane prepared 
without a crosslinker than the polyurethane prepared with a crosslinker [35].  The 
polyurethane prepared without a crosslinker had an average tensile strength of 10.5 MPa 
[35].  The polyurethane prepared with a crosslinker had an average tensile strength of 
20.5 MPa [35]. 
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2.10 Breaking Load 
 Kull et al. evaluated the breaking strength of a n-butyl-2-cyanoacrylate adhesive 
called Glubran2 and a fibrin glue called Tissucol.  A dog-bone shaped silicone rubber 
mold mounted on a Teflon plate was created to prepare the dog-bone shaped specimen 
used for testing.  An activator was sprayed on the Teflon plate to trigger polymerization 
of the adhesive.  The adhesive was dispensed into the dog-bone shaped mold and allowed 
to polymerize for 24 h at 25°C room temperature.  The samples were attached to a 
material testing machine equipped with a 100 N load cell and pulled until breakage 
occurred at the reduced section of the dog-bone shaped specimen.  Based on testing three 
samples each of the cyanoacrylate and fibrin glue, the average breaking strength of the 
cyanoacrylate was about 150 times greater than the fibrin glue [36].  However, the 
flexibility of the fibrin glue was vastly better than the cyanoacrylate.  The results of this 
study showed that the n-butyl-2-cyanoacrylate glue was characterized by a greater 
mechanical strength than its fibrin counterpart but lacked the flexibility to conform to the 
shape of tissue. 
 Duffy et al. used a MTS Material Strength Testing Machine to evaluate the 
breaking loads of extraocular muscles adhered to other ocular tissues with 2-octyl 
cyanoacrylate, a scaffold-enhanced 2-octyl cyanoacrylate adhesive, and the natural 
adhesion of the two tissues [7].  Two to five minutes after the tissue adhesion preparation, 
the samples were clamped to the strength testing machine with pneumatic grips and 
attached to a 100 N load cell [7].  The samples were pulled at a constant rate of one 
gravitational force per second until complete separation of the two tissues [7].  The 
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maximum load was obtained when the two tissues completely separated [7].  Table 4 
shows the average breaking loads of extraocular muscle-to-sclera, sclera-to-sclera, and 
extraocular muscle-to-extraocular muscle adhesions when certain sample adhesives were 
and were not applied.  All three adhesions indicate that the scaffold-enhanced 2-octyl 
cyanoacrylate adhesive required a larger load to break the adhesion between the tissues 
than 2-octyl cyanoacrylate alone.  The native extraocular muscle-to-extraocular muscle 
adhesion required a larger load to completely separate the two tissues than 2-octyl 
cyanoacrylate alone and a scaffold-enhanced 2-octyl cyanoacrylate adhesive [7]. 
Table 4. The mean breaking loads with the standard deviations measured in grams.  
PLGA and SIS were scaffolds used in conjunction with the 2-octyl cyanoacrylate 
adhesive that required a higher breaking load to separate the two tissues [7].  
(Reprinted from J. AAPOS, 9, M.T. Duffy, J.N. Bloom, K.M. McNally-Heintzelman, 
D.L. Heintzelman, E.C. Soller and G.T. Hoffman, Sutureless Ophthalmic Surgery:  A 
Scaffold-Enhanced Bioadhesive Technique, 315-320, 2005, with permission from 
Elsevier)  
 
2-Octyl 
Cyanoacrylate 
Alone
2-Octyl 
Cyanoacrylate 
+ PLGA
2-Octyl 
Cyanoacrylate 
+ SIS Native Muscle
Extraocular Muscle-to-
Sclera Adhesions (g) 248 ± 43 432 ± 21 424 ± 23 257 ± 41
Sclera-to-Sclera 
Adhesions (g) 251 ± 37 404 ± 21 399 ± 24 N/A
Extraocular Muscles-
to-Extraocular Muscle 
Adhesions (g) 369 ± 35 561 ± 21 571 ± 24 631 ± 36  
 
2.11 Adhesive Force 
 When assessing the adhesive force of a tissue adhesive not on tissue, two types of 
peel tests are commonly performed.  The first type of test is the single-arm 90° peel test.  
This version of the peel test has a rigid base plate bolted onto a linear bearing, which is 
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mounted on a universal testing machine [37].  The free part of the peel arm is bent around 
a roller so that it can be clamped by the upper grip of the testing machine and can provide 
a 90° peel angle [37].  The peel test is conducted by peeling the peel arm with a constant 
crosshead speed measured in millimeters per minute [37].  The force required to fracture 
the adhesive bond is obtained at the conclusion of this test.  Figure 13 portrays the 
concept of a single-arm 90° peel test. 
 
Figure 13. The single-arm 90° peel test.  The height of the adhesive and peel arm are 
represented by ha and hs, respectively.  The peel angle with respect to the load line is 
denoted by θ.  The load experienced when pulling the adhesive is represented by P [37].  
(Reprinted from Eng. Fract. Mech., 73, H. Hadavinia, L. Kawashita, A.J. Kinloch, D.R. 
Moore and J.G. Williams, A numerical analysis of the elastic-plastic peel test, 2324-
2335, 2006, with permission from Elsevier)  
 
 The second type of peel test is the T-peel test.  This kind of peel test attaches the 
adhesive sample between the peel arms of the universal testing machine, and the peel 
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arms are allowed to rotate freely [37].  Unlike the single-arm 90° peel test, the T-peel test 
has both peel arms pull apart from the vertical axis and the force required to fracture the 
adhesive bond is measured [37].  The crosshead speed remains constant measured in 
millimeters per minute.  Figure 14 illustrates how the T-peel test works. 
 
Figure 14. The T-peel test.  The peel arms are perpendicular to the horizontal axis.  The 
load experienced when pulling the adhesive is represented by P [37].  (Reprinted from 
Eng. Fract. Mech., 73, H. Hadavinia, L. Kawashita, A.J. Kinloch, D.R. Moore and J.G. 
Williams, A numerical analysis of the elastic-plastic peel test, 2324-2335, 2006, with 
permission from Elsevier)  
 
 Lee and Tsao used the single-arm 90° peel test to measure the adhesive force.  
They used a Lloyd LRX Universal Tester to measure the adhesive force and set the 
crosshead speed at 30 mm/min [25].  The adhesive force for various concentrations of 
silver nanoparticles in the hydrogel is tabulated in Table 5.  The results from the test 
showed that the increase of silver nanoparticle concentration yields a slight decrease in 
adhesive force. 
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Table 5. The adhesive force for various concentrations of silver nanoparticles in the 
hydrogel.  As there was an increase of silver nanoparticle concentration in parts per 
million in the hydrogel, the adhesive force slightly decreased [25].  (Reprinted from J. 
Mater. Sci., 45, W-F. Lee and K-T. Tsao, Effect of silver nanoparticles content on the 
various properties of nanocomposite hydrogels by in situ polymerization, 89-97, 
2010, with permission from Springer Science and Business Media)  
 
Silver Nanoparticle Concentration (ppm) Adhesive Force (g/cm2)
0 16.73 ± 0.3%
55.6 16.32 ± 1.6%
83.4 16.22 ± 1.3%
111.2 15.61 ± 0.7%
139 14.99 ± 0.2%  
 
 Chivers et al. evaluated the adhesive properties of several common tissue 
adhesives, such as cyanoacrylate, gelatin-based adhesive, and fibrin [38].  They tested the 
adhesive strength of the adhesive to porcine skin, bone, and cartilage.  Porcine skin is a 
common substrate used for measuring adhesive properties of an adhesive.  Adhesive was 
applied in between overlapping skin and then allowed to cure.  This specimen was then 
clamped by the grips of the universal testing machine and pulled at 5 mm/min until the 
bond completely failed [38].  The strength of the adhesive was highly dependent on the 
test substrate.  As shown in Table 6, cyanoacrylate displayed the greatest adhesive 
strength over gelatin-based adhesive and fibrin [38].  
Table 6. The mean adhesive force for the three adhesives bonded to the three different 
substrates.  Cyanoacrylate showed the greatest adhesive strength [38].  (Reprinted 
from Int. J. Adhes. Adhes., 17, R.A. Chivers and R.G. Wolowacz, The strength of 
adhesive-bonded tissue joints, 127-132, 1997, with permission from Elsevier)  
 
 
Adhesive Strength (MPa)
Cartilage Bone Skin
n-Butyl-2-cyanoacrylate 1.00 1.40 1.20
Gelatin/resorcinol/formaldehyde 0.15 0.20 0.07
Fibrin 0.0049 0.0110 0.0190
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2.12 Curing Time 
 Cyanoacrylate tissue adhesives polymerize on contact with moisture such as water 
and blood [10,11].  Upon contact with liquid substances, a strong bond is formed between 
the adhesive and tissue.  The application of one drop of 2-octyl cyanoacrylate as a smooth 
single layer on the wound takes 15 to 30 s to fully polymerize and dry [11].  When 
increasing the droplet amount of 2-octyl cyanoacrylate to two to three drops, it takes two 
minutes to fully polymerize and dry as a thin, uniform layer on the wound [10]. 
2.13 Transparency 
 After the polymerization and drying time of 2-octyl cyanoacrylate, Meskin et al. 
reported that a gray-to-white meshwork of the adhesive formed on the corneal wound as a 
barrier [11].  The 51 patients involved with this study did not report any obstruction of 
vision or decline of visual acuity after the adhesive was applied.  During the second 
postoperative visit after cataract surgery, 8 of the 51 patients experienced mild staining 
on the clear corneal wound edges or a mildly irregular epithelium [11].  Nevertheless, 
Meskin and his group reported that all patients met the safety criteria and regained their 
vision soon after the procedure. 
2.14 Summary 
 Tissue adhesives are a safe and effective alternative to sutures when treating 
wounds around the body.  Due to the delicate nature of ocular tissue, tissue adhesives will 
not inflict any mechanical damage onto the eye.  The desirable mechanical and 
antibacterial properties suggest that a silver nanoparticle-infused tissue adhesive would 
minimize wound healing time and reduce the possibility of infection. 
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The areas investigated in this literature review offer insights on how to develop a 
silver nanoparticle-infused tissue adhesive for ophthalmic use.  The tissue adhesive with 
a short curing time and favorable sealing and mechanical properties is 2-octyl 
cyanoacrylate.  The size, shape, and concentration need to be considered because of its 
relevance in determining the antibacterial effectiveness of silver nanoparticles.  With 
these parameters discussed in this chapter, a functional silver nanoparticle-infused tissue 
adhesive for ophthalmic use was developed in this research. 
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CHAPTER THREE 
OBJECTIVE 
3.1 Objective 
 The objective of this research was to evaluate the effects of silver nanoparticle 
infusion on the antibacterial efficacy, adhesive strength, and breaking strength of a 2-
octyl cyanoacrylate tissue adhesive as a function of nanoparticle size and concentration.  
Before evaluating the antibacterial and mechanical properties of the silver nanoparticle-
infused tissue adhesive, uniform distribution of the silver nanoparticles in the adhesive 
needed to be achieved.  The antibacterial effectiveness of the composite adhesive was 
determined via the Kirby-Bauer disk diffusion susceptibility test and CFU counting.  The 
adhesive force to a porcine sclera and breaking load of the silver nanoparticle-infused 2-
octyl cyanoacrylate tissue adhesive were the mechanical properties evaluated.  Generated 
results from these tests were compared to the results of a control sample composed of an 
unaltered version of the 2-octyl cyanoacrylate tissue adhesive. 
3.2 Justification 
 Tissue adhesives are safe alternatives to mechanical fasteners when treating 
ocular wounds.  Using sutures on delicate ocular tissue or allowing self-healing increases 
the risk of infection and healing time.  Currently, tissue adhesives are used for ophthalmic 
applications; however, the potential for infection is still present if the wound is not 
properly cleansed.  The addition of silver nanoparticles to a 2-octyl cyanoacrylate tissue 
adhesive was proposed to reduce the potential for infection. 
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CHAPTER FOUR 
MATERIALS AND METHODS 
4.1 Overview 
A 2-octyl cyanoacrylate tissue adhesive provides a safe alternative to using 
mechanical fixtures when treating wounds.  Using mechanical fixtures on tissue causes 
discomfort to patients and occasionally inflicts damage beyond what is necessary [6].  
Furthermore, there is a risk of inflammation or infection on the wound when using 
mechanical fixtures.  If a tissue adhesive is used to treat an improperly cleansed wound, 
there is also a possibility of inflammation and infection.  The infusion of silver 
nanoparticles into a 2-octyl cyanoacrylate was proposed to reduce the potential for 
infection because of the notable bactericidal effect of silver nanoparticles. 
4.2 Materials 
 The two main materials tested in this experiment were silver nanoparticles and a 
2-octyl cyanoacrylate tissue adhesive.  The 4 nm and 10 nm size silver nanoparticles 
(NanoXact, nanoComposix) were dried powders redispersed in 99.7+% chloroform (IBI 
Scientific) and 99.5+% anhydrous ethanol (Fisher Scientific), respectively.  The brand of 
the 2-octyl cyanoacrylate tissue adhesive was Dermabond® (Ethicon, Inc.), which is a 
high viscosity tissue adhesive that comes in individual 0.5 mL vials.  All samples that 
needed to be specifically shaped for their respective tests were formed in a 
polyacrylamide mold, which was composed of 99.9% N,N’-methylenebisacrylamide 
(bisacrylamide; UltraPure™, Life Technologies), 98.5+% acrylamide (Fisher Scientific), 
98% ammonium persulfate (APS; Fisher Scientific), 95+% N,N,N',N'-
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tetramethylethylenediamine (TEMED; Fisher Scientific), and deionized water.  For the 
antibacterial testing, E. coli (San José State University, Department of Biological 
Sciences) were the bacteria used and were incubated on a solid LB agar (Miller, Fisher 
Scientific) and LB broth (Lennox, Fisher Scientific) filled culturing dish.  In the breaking 
load testing of the experiment, the silver nanoparticle-infused tissue adhesive was molded 
into a dog-bone shaped specimen.  For the adhesive force testing, the composite adhesive 
was applied onto the sclera of a porcine eye (Mi Pueblo Food Center).  The porcine eyes 
were kept in sterile Ringer’s solution and were stored in a refrigerator.  The Ringer’s 
solution was composed of sodium chloride, potassium chloride, and calcium chloride.  
The handling and disposal of porcine eyes was in compliance with the regulations set 
forth by the San José State University Institutional Animal Care and Use Committee 
(IACUC). 
4.3 Equipment 
 The silver nanoparticles were dispersed into the adhesive with a vortex (S/P® 
Vortex Mixer, Baxter Diagnostics Inc.) and indirect sonicator.  The composite adhesive 
sample container was placed in a cold water bath and ultrasonic energy was propagated 
through the medium via the sonicator.  Transmission electron microscopy (1010, JEOL) 
produced high resolution images of the sample to ensure the uniform distribution of the 
silver nanoparticles within the adhesive. 
 An autoclave (SS-320, Tomy) sterilized the liquid media used for the 
experiments.  The antibacterial testing portion of the experiment required the handling of 
bacteria in a biosafety cabinet (1100, Forma Scientific).  An incubator (B 5060, Heraeus 
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Instruments) was used to grow the bacterial colonies and also incubate the bacteria with 
the silver nanoparticle-doped adhesive.  An inverted microscope (Eclipse Ti, Nikon) was 
used to observe the inhibition halos surrounding the adhesive samples for the Kirby-
Bauer disk diffusion susceptibility test.  To test the breaking load and adhesive force of 
the adhesive, an Instron (4204) universal testing machine was the analytical instrument 
used.  The adhesive force setup also included securing a porcine eye in a vacuum eye 
holder that was connected to an Edwards (RV12) rotary vane pump for vacuum suction.  
The vacuum eye holder was comprised of everyday items, such as a wooden frame, 
tubing, ½” x ¾” pipe adapter, and ½” barb elbow fitting that are typically used for a 
water sprinkler system (Orbit Sprinklers).  The pipe adapter held the eye while the barb 
elbow fitting connected the adapter to the tubing connected to the rotary vane pump.  The 
experiments were performed at San José State University. 
4.4 Materials and Equipment Safety 
 Personal protective equipment (PPE) was worn when handling all of the materials 
involved in this experiment.  The PPE worn included nitrile gloves, goggles, lab coat, 
long sleeve shirt, pants, and closed-toe shoes.  Before preparing and conducting any of 
the experiments, training for using the equipment and materials was conducted.  Table 7 
organizes the safety precautions for the materials necessary for this experiment. 
 
 
 
46 
 
Table 7. Safety precautions for each material used in this experiment.  These 
precautions include hazards, handling, storage, emergency response plan, spill and 
leak procedures, and waste disposal procedures.  
 
 
Material Hazards Handling Storage Emergency 
Response Plan
Spill and Leak 
Procedures
Waste Disposal 
Procedure
Silver 
nanoparticles
Skin, eyes, 
respiratory, 
digestive tract 
irritant [39]
PPE, avoid 
inhalation and 
ingestion [39]
Store in closed 
bottle, store at 2-
25°C away from 
light [40]
For fire, use 
water, carbon 
dioxide [39]
Sweep, dilute 
with water, wipe 
surface with 
cleaner [39]
Dispose of 
according to 
regulations [39]
2-octyl 
cyanoacrylate 
Dermabond®
Polymerizes 
rapidly on contact 
with tissue [41,42]
PPE [41]
Store below 
30°C away from 
moisture, heat 
[41,42]
Use petroleum 
jelly to loosen 
bond on skin 
[41]
Polymerize with 
water, pick up 
with inert 
material [41,42]
Dispose in non-
hazardous solid 
waste [41]
LB agar and 
LB broth
Skin, respiratory, 
digestive tract 
irritant [43,44]
PPE, avoid 
inhaling vapors, 
eye and skin 
contact [43,44]
Store in closed 
container in a 
dry, ventilated 
area [43,44]
Wash eyes, 
skin with water 
[43,44]
Sweep up and 
dispose in 
closed container 
[43,44]
Give product to 
disposal 
company 
[43,44]
Escherichia 
coli
Causes 
hemorrhagic 
colitis, abdominal 
pain [45]
PPE, frequent 
hand washing 
[45]
Store in 
appropriately 
labeled sealed 
containers [45]
Electrolyte 
fluid therapy, 
use antibiotics 
in severe cases 
[45]
Absorb spill 
with paper 
towel, sodium 
hypochlorite 
[45]
Decontaminate, 
sterilize, 
disinfect [45]
Porcine eyes
Biohazard if not 
handled properly
PPE, frequent 
hand washing
Refrigerate in 
Ringer's solution
Contact 
physician if 
become sick
Dispose in 
biohazard 
container
Dispose in 
biohazard 
container
Anhydrous 
Ethanol
Flammable, 
carcinogen. Skin, 
eye, respiratory 
irritant [46]
PPE, avoid 
inhaling vapors 
or mist [46]
Store in closed 
container away 
from flammables 
[46]
For fire, use 
water, carbon 
dioxide [46]
Contain spillage, 
place in 
appropriate 
container [46]
Dispose via 
waste disposal 
service [46]
Chloroform
Carcinogen. Skin 
and eye irritant 
[47]
PPE, avoid 
inhaling vapors 
[47]
Store in closed 
container away 
from light [47]
Wash skin and 
eyes with 
water [47]
Contain spillage, 
place in 
container [47]
Dispose of 
according to 
regulations [47]
Acrylamide
Causes genetic 
damage, infertility, 
allergic reaction.  
Neurotoxin, 
carcinogen [48]
PPE, use fume 
hood, avoid eye 
and skin contact, 
inhalation [48]
Store in closed 
container, 
refrigerate, away 
from sunlight 
[48]
Rinse eyes, 
wash skin with 
soap and 
water [48]
Wear breathing 
apparatus, 
protective suit.  
Sweep into 
container [48]
Dispose of 
according to 
regulations [48]
Bisacrylamide
Eye, skin irritant.  
Causes 
reproductive harm 
[49]
PPE, use fume 
hood, avoid eye 
and skin contact, 
inhalation [49]
Keep in a cool, 
dry, ventilated 
area [49]
Rinse eyes, 
wash skin with 
soap and 
water [49]
Sweep or 
vacuum into 
suitable 
container [49]
Dispose of 
according to 
regulations [49]
Ammonium 
persulfate
Combustible, 
organic material.  
Respiratory, skin, 
eye irritant [50]
PPE, use fume 
hood, avoid eye 
and skin contact, 
inhalation  [50]
Keep in a cool, 
dry, ventilated 
area, away from 
flammables [50]
Rinse eyes, 
wash skin with 
soap and 
water [50]
Sweep, vacuum 
into suitable 
container [50]
Dispose of 
according to 
regulations [50]
TEMED
Causes burns, 
pulmonary edema. 
Harmful if inhaled, 
ingested.  
Flammable [51]
PPE, use fume 
hood, avoid eye 
and skin contact, 
inhalation [51]
Keep in a dry, 
ventilated area, 
away from 
flammables [51]
Rinse eyes, 
wash skin with 
soap and 
water [51]
Absorb with 
inert material.  
Keep in suitable 
container [51]
Dispose of 
according to 
regulations [51]
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 Formal training before operating the equipment used in this experiment was 
conducted to educate the operator of potential hazards and to teach proper usage.  When 
using a sonicator, the operator needed to wear earplugs to protect his ears from the high 
frequency of the ultrasonic energy.  The autoclave also possesses hazards if not properly 
used.  Since a high temperature and pressure were set during sterilization, the autoclave 
was allowed to cool before opening [52].  The operator needed to stand back and open 
the door slowly to let the extra steam escape [52].  Once these precautions were taken, 
thick gloves were used to remove the hot items [52]. 
The rotary vane pump created a vacuum by the rotation of the pump-motor inside 
the containing cavity [53].  Oil was used to lubricate the moving parts of the pump and 
posed as a safety hazard.  The operator needed to avoid prolonged skin contact and 
inhaling the oil mist [53].  Furthermore, the instrument casing was hot during and after 
operation and can cause burns if carried [53].  The operator needed to be careful of 
moving parts when using the universal testing machine. 
4.5 Experimental Methodology 
4.5.1 Experimental Matrix 
 To fulfill the objective of this research, the antibacterial effectiveness, breaking 
load, and adhesive force of the silver nanoparticle-infused tissue adhesive were 
measured.  The two measured factors were the silver nanoparticle concentration and size.  
These factors were each measured at a high and low level.  For the silver nanoparticle 
concentration, the high and low level concentrations were 10 μg/mL and 1 μg/mL, 
respectively.  The high and low silver nanoparticle size levels were 10 nm and 4 nm, 
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respectively.  These factors and levels are organized in an experimental matrix in Table 8 
to aid in designing an experiment that demonstrates the effect of silver nanoparticle 
concentration and size on the antibacterial efficacy, breaking load, and adhesive force of 
the 2-octyl cyanoacrylate tissue adhesive. 
Table 8. The experimental matrix containing varying levels of each factor.  Since 
there were two factors being varied, there were four runs that were conducted for 
each test.  A control sample was also evaluated for each test.  The plus (+) sign 
represents a high level, and the minus (-) sign represents a low level.  
 
Standard Order Silver Nanoparticle Concentration Silver Nanoparticle Size
1 - -
2 + -
3 - +
4 + +  
 
 Each of the three tests used 2-octyl cyanoacrylate alone as a control.  The 
experiment was conducted five times to ensure reliability of the data.  Repeating the 
experiment provided varying ranges of response data and allowed for the determination 
of errors in each run.  Data analysis was performed to conclude the effect silver 
nanoparticle concentration and size has on the adhesive’s antibacterial and mechanical 
properties.  Additionally, the responses of the tissue adhesive containing varying factors 
were compared to the responses generated by the tissue adhesive alone.  These response 
comparisons established if the infusion of silver nanoparticles into the 2-octyl 
cyanoacrylate tissue adhesive was advantageous over the tissue adhesive alone.  To 
summarize the steps involved in this experiment, Figure 15 shows a flowchart depicting 
each step of the experimental process. 
49 
 
 
Figure 15. Flowchart illustrating the steps involved with this experiment.  
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4.5.2 Infusion of Silver Nanoparticles into the Tissue Adhesive 
 Varying concentrations and sizes of silver nanoparticles were added to a 2-octyl 
cyanoacrylate tissue adhesive via vortexing and indirect sonication.  Vortexing provided 
initial mixing of the silver nanoparticles into the liquid tissue adhesive.  Indirect 
sonication was used because the ultrasonic energy evenly disperses the nanoparticles 
within the tissue adhesive.  Results will be subject to additional variability and will not be 
repeatable if the silver nanoparticles were not evenly distributed within the tissue 
adhesive.  These dispersion techniques were important to this experiment because of the 
relatively quick polymerization of 2-octyl cyanoacrylate on contact with moisture.  
Typically, dried silver nanoparticles must first be added to a solvent and vortexed and 
sonicated to be dispersed and unagglomerated. 
The 10 nm silver nanoparticle surfaces were received from the manufacturer 
coated with polyvinylpyrrolidone to prevent agglomeration after dispersion into a polar 
solvent.  There are a variety of polar solvents in which silver nanoparticles are soluble.  
Since 2-octyl cyanoacrylate quickly polymerizes when in contact with moisture, an 
anhydrous solvent was the best choice to slow the polymerization and allow for more 
control of the adhesive.  An anhydrous, 200 proof, 99.5+% ethanol was used as the 
solvent to allow high solubility for the silver nanoparticles.  The 4 nm silver 
nanoparticles has a dodecanethiol capping agent.  These organically functionalized silver 
nanoparticles can be redispersed in various polar organic solvents.  A 99.7+% chloroform 
was the selected solvent because of the high solubility of silver nanoparticles in this 
solvent and its relative safety compared to other polar organic solvents.  These coatings 
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should displace from the silver nanoparticles when added to the appropriate solvent [54].  
The solvents were added to their respective silver nanoparticle containers and were 
vortexed for 10 s and sonicated for 30 s to produce a homogenous solution.  The solvents 
were not added to the unaltered adhesive control samples. 
 Vortexing and indirect sonication were ideal methods to disperse the small 
amounts of 2-octyl cyanoacrylate and silver nanoparticles used in these experiments.  
This was because vortexing and sonicating provided quick and homogeneous mixing of 
the silver nanoparticles into the adhesive.  Indirect sonication was also ideal because of 
the reduction of heat resulting from direct ultrasonic energy.  Indirect sonication involved 
the immersion of the liquid sample container into a cold water bath while ultrasonic 
waves were sent through the bath [29].  Continuous mode operation was adequate for 
dispersing the nanoparticles within the adhesive.  The tissue adhesive and redispersed 
silver nanoparticles were added to a 1.5 mL microcentrifuge tube and were vortexed for 
10 s and indirectly sonicated for 30 s to obtain a homogeneous solution.  If the 
nanoparticle and adhesive mixture was not homogeneous, additional vortexing and 
sonication was performed.  Figure 16 shows the addition of silver nanoparticles to the 
adhesive before and after vortexing and sonication. 
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Figure 16. The addition of silver nanoparticles to the tissue adhesive prior (top) and after 
(bottom) vortexing and sonication.  
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4.5.3 Silver Nanoparticle Distribution Within Adhesive 
 The distribution of silver nanoparticles within the tissue adhesive was observed 
with a TEM.  The TEM images the transmitted beam of electrons through the sample to 
generate an image of the silver nanoparticles within the tissue adhesive [55].  A 0.5 mL 
vial of the adhesive and 0.5 mg container of dried 10 nm silver nanoparticles were sent 
for TEM analysis (nanoComposix).  The anhydrous ethanol was not sent along with the 
adhesive and nanoparticles because of the possible container breakage and exposure of 
the flammable ethanol to an ignition source.  The silver nanoparticles were redispersed in 
anhydrous ethanol by the tester.  We provided instructions on how to prepare the 
composite sample as we would for our testing.  The silver nanoparticle composite 
adhesive was prepared by adding 50 μL of adhesive to a container holding 10 μg/mL of 
silver nanoparticles, vortexing for 10 s, and indirectly sonicating for 30 s to obtain a 
homogeneous solution.  Image acquisition was performed and images were sent back for 
our use.  ImageJ, which is an image processing and analyzing program developed by the 
National Institutes of Health (NIH), was used to evaluate the distribution of particle 
spacing.  First, the scale was set to the length of the scale bar from the provided image.  
The Line tool was used to draw a line from the center of a particle to the center of an 
adjacent particle.  The length of the line was measured by ImageJ and the results of the 
analysis were displayed.  Measuring the spacing between particles were performed for all 
particles and ultimately summarized by the ImageJ software. 
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4.5.4 Preparing Samples in Polyacrylamide Mold 
 A polyacrylamide mold was used to shape the samples for their respective testing.  
Polyacrylamide was chosen due to its water content, which aids in the polymerization of 
the 2-octyl cyanoacrylate adhesive when poured into the mold and can be rehydrated if 
needed.  Polyacrylamide was also chosen to be the mold because of its flexibility that 
allowed easy removal of samples from the mold.  The mold formed the disks and dog-
bone shaped specimens for the Kirby-Bauer test and breaking load test, respectively.  
This polyacrylamide mold was created by being formed on an inverted solid mold.  The 
disk and dog-bone shapes on the solid mold were extruded outward to form the 
polyacrylamide mold, which allowed the adhesive to be poured into the mold.  The disks 
used for the Kirby-Bauer test had a diameter of 6.35 mm and a thickness of 1.5875 mm.  
The dog-bone specimens used for the breaking load test have a reduced section of 6.35, 
1.5875, and 1.5875 mm as the length, width, and thickness, respectively.  Bulk high-
density polyethylene (HDPE) was machined to create the solid mold and is pictured in 
Figure 17. 
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Figure 17. Machined high-density polyethylene (HDPE) solid mold used to form the 
polyacrylamide mold for preparing samples for the breaking load test.  
 
 Refining the formulation of the polyacrylamide mold to the desired flexibility and 
durability required multiple attempts.  Since unpolymerized acrylamide is a neurotoxin, 
every step of this procedure was performed in a fume hood.  The bottom of the solid 
mold was taped to a 100 mm diameter culturing dish using double-sided tape before 
preparing the polyacrylamide solution.  In order to create a 20 mL solution of acrylamide, 
0.0199 g of bisacrylamide was added to 3.9801 g of acrylamide and mixed with 
deionized water until reaching 20 mL.  In a separate container, 0.2 g of APS was added to 
2 mL of deionized water.  The APS was then mixed with the acrylamide solution.  
Quickly afterward, 7 μL of TEMED was dispensed into the acrylamide and APS mixture 
and stirred vigorously before being poured into the culturing dish containing the solid 
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mold.  APS and TEMED catalyzed the polymerization of acrylamide and generated the 
polyacrylamide in 30 min.  Figure 18 depicts the freshly made polyacrylamide mold. 
 
Figure 18. The polyacrylamide mold used to form the samples used for breaking load 
testing.  The mold was placed in a 100 mm diameter culturing dish. 
 
4.5.5 Antibacterial Effectiveness Testing 
Before testing the antibacterial efficacy of the composite tissue adhesive, E. coli 
fed with LB broth was grown on sterilized solid agar within a culturing dish.   LB broth 
was prepared by mixing 25 g of the powder to 1,000 mL of deionized water.  Similarly, 
LB agar was prepared by mixing 37 g of the powder to 1,000 mL of deionized water.  
These amounts and volumes were general ratios and were scalable to whatever final 
volume of material needed.  The LB broth and LB agar were then placed into the 
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autoclave for 20 min at 121°C to be sterilized.  Upon completion of sterilization, the 
containers of broth and agar were removed and set aside to be cooled down.  The agar 
was poured into 60 mm diameter culturing dishes when the agar was slightly cooled to be 
safely held and poured but remained at low viscosity.  The agar gradually solidified and 
was placed into the refrigerator along with the LB broth. 
The Kirby-Bauer test sample preparation started by adding a colony of E. coli to 
10 mL of LB broth within a 15 mL conical centrifuge tube and placed in an incubator at 
37°C for 16 h.  The conical centrifuge tube was taken out after the time has elapsed and 
vortexed for five seconds.  A single-channel adjustable pipet was used to pipet 25 μL of 
the E. coli in LB broth solution onto the solidified agar within the culturing dish.  The 
narrow portion of a glass Pasteur pipet was flamed and bent into a L-shape to be used to 
spread the E. coli in LB broth solution on the agar.  Next, the adhesive samples were 
prepared on a polyacrylamide mold.  After the 6.35 mm diameter by 1.5875 mm thick 
disk-shaped sample was formed, the sample was placed onto the culturing dish and 
incubated for 16 h at 37°C.  During the 16 h of incubation, the sample absorbs water from 
the agar plate while the silver diffuses into the surrounding agar [26,34].  If the bacteria 
were susceptible to the antibacterial property of silver nanoparticles, then an inhibition 
halo formed around the composite adhesive sample.  To prove the antibacterial 
effectiveness of the silver nanoparticles, a disk of unaltered tissue adhesive served as a 
control, which should not produce an inhibition halo.  We hypothesized that altering 
silver nanoparticle concentration and size will affect the diameter of the inhibition halo, 
thus indicating variation in antibacterial efficacy.  The determination of the presence of 
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an inhibition halo surrounding the samples was observed after 16 h.  All inhibition halo 
diameters of the samples were measured with a caliper and recorded. 
CFU counting was another quantitative measurement of antibacterial 
effectiveness of the silver nanoparticle-imbued 2-octyl cyanoacrylate tissue adhesive.  
The samples from the Kirby-Bauer test were prepped to be used for the CFU counting 
test.  The samples from that test were first added to 10 mL of LB broth within a 15 mL 
conical centrifuge tube, which was vortexed for 10 s and indirectly sonicated for 30 s.  
Vortexing and sonication was repeated two more times.  This solution was diluted to five 
different orders of magnitude: 10-1, 10-2, 10-3, 10-4, and 10-5.  To dilute the solution to 10-
1, 100 μL of the sample solution from the conical centrifuge tube was drawn by a single-
channel adjustable pipet and dispensed into a 1.5 mL microcentrifuge tube containing 
900 μL of LB broth.  The new diluted solution was aspirated and dispensed three times in 
the microcentrifuge tube to ensure thorough mixing.  Next, 100 μL of this diluted 
solution was drawn, dispensed, and mixed into another 1.5 mL microcentrifuge tube 
containing 900 μL of LB broth to produce the 10-2 diluted solution.  This process was 
repeated until reaching the 10-5 diluted solution.  After all dilutions were completed, 25 
μL of the 10-5 diluted solution was dispensed onto solid agar within a culturing dish and 
was spread with a flamed, L-shaped glass Pasteur pipet.  This spreading of diluted sample 
solution was repeated for the 10-4 dilution all the way to 10-1 in that sequential order.  The 
culturing dishes were then placed into the incubator for 18 h at 37°C.  This entire sample 
preparation process was repeated for all adhesive samples.  After the incubation time, the 
culturing dishes were removed from the incubator and the E. coli colonies of each dish 
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were counted.  There should be a noticeable reduction of colonies as the samples were 
more diluted.  We hypothesized that an unaltered version of 2-octyl cyanoacrylate will 
produce a higher CFU count than the silver nanoparticle-doped tissue adhesive samples.  
Pictures of the samples were taken with a camera (DSC-P200, Sony) at 1X magnification 
to be processed and analyzed in ImageJ. 
4.5.6 Breaking Load Testing 
 The breaking load of the silver nanoparticle-infused tissue adhesive was measured 
with the universal testing machine.  Samples were prepared by dispensing the adhesive 
into the individual dog-bone shaped mold on the polyacrylamide mold to polymerize and 
dry.  After the adhesive polymerized, each end of the sample was clamped by the 
pneumatic grips of the universal testing machine, which is shown in Figure 19.  The user 
entered 6.35, 1.5875, and 1.5875 mm as the length, width, and thickness of the reduced 
section of the adhesive sample into Instron’s Bluehill® 3 instrument software before the 
test began.  The universal testing machine was equipped with a 100 N load cell to detect 
the breaking load of the composite adhesive, which was found when the sample fractured 
and completely separated.  The sample was pulled apart by the universal testing machine 
at a rate of 1 mm/min until the sample fractured.  The raw data was recorded and initially 
analyzed by the Bluehill® 3 software.  The raw data was obtained and further analyzed in 
Microsoft Excel to assess the effects of silver nanoparticles on the breaking load of the 
tissue adhesive. 
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Figure 19. Dog-bone shaped specimen clamped by the grips of the universal testing 
machine.  The adhesive sample’s length, width, and thickness of the reduced section were 
6.35 mm, 1.5875 mm, and 1.5875 mm, respectively.  
 
4.5.7 Adhesive Force Testing 
 This test examined the adhesive force of the composite tissue adhesive on porcine 
eye tissue.  First, a 3.0 mm incision was made on the sclera of the porcine eye.  A 50 μL 
amount of adhesive was then applied as a smooth single layer to the incised ends of the 
sclera while the two ends of the tissue were held together.  A machined T-structure was 
attached to the other side of the adhesive and the operator applied force to the bonded 
area for five minutes to allow the adhesive to polymerize.  Figure 20 shows the T-
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structure attached to the porcine sclera.  The T-structure was wooden because the wood 
will not fracture before the adhesive bond fractures.  The eye was then placed into a 
vacuum eye holder and rotated in a way such that the area of the incised sclera was not 
secured by the eye holder.  The eye holder is pictured in Figure 21.  The eye holder was 
tightened by the lower grip of the universal testing machine and connected with a tube to 
the rotary vane pump that provided vacuum suction.  Figure 22 illustrates the setup for 
the adhesive force testing. 
 
Figure 20. The T-structure adhered to the porcine sclera prior to placing into the vacuum 
eye holder.  The bonding surface of the T-structure was 13 mm wide and 13 mm long.  
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Figure 21. The eye holder that held the eye in the pipe adapter.  The tube connected the 
eye holder to the rotary vane pump to provide vacuum suction.  
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Figure 22. The adhesive force experimental setup.  The rotary vane pump was positioned 
on the cart (far left), while the eye holder was clamped onto the universal testing 
machine.  
 
 The upper pneumatic grip was lowered until the vertical section of the T-structure 
was clamped to the grips.  The operator entered the length, width, and thickness of the 
bonded area of the adhesive to the eye into the Bluehill® 3 software before testing 
started.  The 100 N load cell was also used for this test and was pulled at a rate of 5 
mm/min until the adhesive bonds between the porcine eye and the adhesive fractured.  
The force required to break the adhesive bonds is called the adhesive force.  Similar to 
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the other performed tests, an unaltered tissue adhesive was used as a control.  The raw 
data was generated by the Bluehill® 3 software and Microsoft Excel was used to evaluate 
the effects the silver nanoparticles has on the adhesive force of the tissue adhesive when 
tested on porcine eyes. 
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CHAPTER FIVE 
RESULTS 
5.1 Silver Nanoparticle Distribution within Tissue Adhesive 
 The TEM images showed uniform distribution of the silver nanoparticles within 
the 2-octyl cyanoacrylate.  Figure 23 displays the distribution of the 10 nm silver 
nanoparticles within the tissue adhesive.  The spacing between the particles for four TEM 
images was on average 37.2 nm, with a standard deviation of 14.4 nm.  The raw data for 
the ImageJ analysis of the spacing between particles are located in Appendix A.  The 4 
nm and 10 nm silver nanoparticles were also imaged to confirm the particle size.  The 4 
nm particle size is pictured in Figure 24, while the 10 nm particle size is shown in Figure 
25.  The 4 nm and 10 nm particle sizes represented the median sizes.  In terms of the 
silver nanoparticle size distribution, the 10 nm nanoparticles exhibited a 12.3% 
coefficient of variation, while the 4 nm nanoparticles exhibited a 15.6% coefficient of 
variation. 
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Figure 23. TEM image of the 10 nm silver nanoparticles distributed within 2-octyl 
cyanoacrylate.  The image is at 80,000X magnification.  
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Figure 24. TEM image of the 4 nm silver nanoparticles to confirm the particle size.  The 
image is at 100,000X magnification.  
 
 
 
 
Figure 25. TEM image of the 10 nm silver nanoparticles to confirm the particle size.  The 
image is at 80,000X magnification.  
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5.2 Antibacterial Efficacy 
 We hypothesized that the infusion of silver nanoparticles into the 2-octyl 
cyanoacrylate tissue adhesive imbues an antibacterial effect to the adhesive.  The Kirby-
Bauer disk diffusion susceptibility test and CFU counting were performed to examine this 
composite adhesive and compared it to an unaltered version of the tissue adhesive.  
Results indicate that the composite adhesive was characterized by a notable decrease of 
bacterial growth than compared to the tissue adhesive alone.  The following sections 
describe the results of the individual antibacterial tests. 
5.2.1 Kirby-Bauer Disk Diffusion Susceptibility Test 
 The objective of this test was to observe if an inhibition halo was present around 
the disk-shaped sample that was placed on top of a culturing dish filled with E. coli.  As 
expected, none of the unaltered 2-octyl cyanoacrylate samples produced a surrounding 
inhibition halo.  The absence of an inhibition halo is seen in Figure 26.  Figure 27 is a 
magnified view of an unaltered adhesive sample using an inverted microscope. 
69 
 
 
Figure 26. An inhibition halo was not formed around the unaltered adhesive.  
 
 
 
Figure 27. Magnified view of an unaltered adhesive sample at 2X magnification.  The E. 
coli was confluent around the sample.  
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 The silver nanoparticle-infused tissue adhesive samples generated a distinct 
inhibition halo surrounding each sample.  This distinct inhibition halo appeared for all the 
varying tested silver nanoparticle concentrations and sizes.  The diameter of the 
inhibition halo was measured with a caliper.  Figure 28 shows a composite sample 
surrounded by a distinct inhibition halo.  An inverted microscope magnified the view of 
the inhibition halo surrounding the sample, which is shown in Figure 29.  Table 9 
tabulates the average inhibition halo of the tested samples.  The raw data for the Kirby-
Bauer test are located in Appendix B.  Figure 30 organizes the average inhibition halo 
diameters by their respective sample combination.  The error bars depict the standard 
deviation of the set of data for each sample.  Table 10 summarizes the results of a 2-way 
analysis of variance (ANOVA) test from the responses generated in the Kirby-Bauer test. 
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Figure 28. A composite sample displaying the presence of an inhibition halo.  
 
 
 
Figure 29. Magnified view of a composite adhesive sample’s inhibition halo at 2X 
magnification.  Notice the distinct halo between the sample and E. coli.  
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Table 10. The results of a 2-way ANOVA test from the responses generated in the 
Kirby-Bauer disk diffusion susceptibility test.  The test statistic (F), critical value (F 
crit), and p-value are shown for the size and concentration factors.  The interaction of 
the size and concentration factors is also shown.  
 
 
 
 
5.2.2 CFU Counting 
 CFU counting provided another test to measure the antibacterial effectiveness of 
the silver nanoparticle-imbued 2-octyl cyanoacrylate tissue adhesive.  This test was 
conducted after the completion of the Kirby-Bauer disk diffusion susceptibility test by 
taking the samples from that test and adding them to LB broth to be diluted to their 
respective order of magnitude.  The samples were diluted to five different orders of 
magnitude: 10-1, 10-2, 10-3, 10-4, and 10-5.  CFU counting allowed for quantitative 
assessment of the degree of bacterial growth.  The E. coli colonies were counted with 
ImageJ.  ImageJ detected the various colors of the image and allowed the user to adjust 
the color threshold and pixel size to be counted.  Allowing the operator to adjust these 
parameters excluded artifactual pixels that possibly greatly alter the colony count.  When 
the user was not able to distinguish the number of distinct colonies in a densely populated 
area on the solid agar, ImageJ separated touching colonies into segments using the 
program’s Watershed algorithm and added the segmentations into the colony count.  This 
analysis with ImageJ was not perfect but does provide a reliable estimate of the number 
of colonies.  Figure 31 compiles the various samples and their respective ImageJ analysis 
Source of Variation F F crit p -value
Concentration 16.3 4.49 9.48E-04
Size 4.08 4.49 6.04E-02
Interaction 19.8 4.49 4.08E-04
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that provided a better resolution of the CFU counts.  Figure 32 shows the serial dilution 
of an unaltered adhesive sample, while Figure 33 shows the serial dilution of a doped 
adhesive sample. 
 
Figure 31. CFU counts for each of the different tested samples.  The pictures on the top 
were the colonies formed on a culturing dish after incubation.  The pictures in the middle 
were the adjusted color threshold that detected the desired colony colors in ImageJ.  The 
pictures on the bottom were the results after ImageJ analyzed the number of colonies in 
the culturing dish.  From left to right, the unaltered adhesive diluted to 10-2 had 1225 
colonies, 1 μg/mL of 4 nm silver nanoparticles within the adhesive diluted to 10-1 had 
520 colonies, 10 μg/mL of 4 nm silver nanoparticles within the adhesive diluted to 10-1 
had 410 colonies, 1 μg/mL of 10 nm silver nanoparticles within the adhesive diluted to 
10-1 had 610 colonies, and 10 μg/mL of 10 nm silver nanoparticles within the adhesive 
diluted to 10-1 had 463 colonies.  
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Figure 32. The serial dilution of an undoped tissue adhesive.  
 
 
Figure 33. The serial dilution of a silver nanoparticle-doped adhesive.  
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 Based on the results from the Kirby-Bauer disk diffusion susceptibility test, an 
unaltered version of 2-octyl cyanoacrylate was found to have a higher CFU count than 
the silver nanoparticle-infused tissue adhesive.  Table 11 displays the average logarithmic 
amount of E. coli colonies present on the different culturing dishes.  The colony counts 
were calculated in the logarithmic scale for simpler and clearer comparison.  The 
standard deviation and p-values were also computed.  The raw data for the CFU counts 
are located in Appendix C.  Figure 34 compares varying concentrations and sizes of 
silver nanoparticles within the tissue adhesive to the original 2-octyl cyanoacrylate.  The 
error bars depict the standard deviation of the set of data for each sample.  Table 12 
summarizes the results of a 2-way ANOVA test from the responses produced in the CFU 
counting. 
Table 11. The average logarithmic amount of E. coli colonies for the different types 
of samples.  The logarithmic values were in base 10.  All runs were performed five 
times.  
 
 
 
 
Name
Average Number of 
Colonies (Logarithmic) Standard Deviation
p -value
(Logarithmic)
Adhesive Alone 4.88 0.16 N/A
1 μg/mL, 4 nm 
AgNP + Adhesive
3.66E-060.163.87
10 μg/mL, 10 nm 
AgNP + Adhesive
3.89 0.13 2.44E-06
1.38E-060.133.81
10 μg/mL, 4 nm 
AgNP + Adhesive
1 μg/mL, 10 nm 
AgNP + Adhesive 3.90 0.11 1.67E-06
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Figure 34. The average CFU counts of various silver nanoparticle concentration and size 
combinations within the 2-octyl cyanoacrylate tissue adhesive.  Average CFU counts are 
depicted on a logarithmic scale.  Error bars represent the standard deviation for each 
sample combination.  
 
 
Table 12. The results of a 2-way ANOVA test from the responses produced in the 
CFU counting.  The test statistic, critical value, and p-value are shown for the size 
and concentration factors.  The interaction of the size and concentration factors is also 
shown.  
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5.3 Breaking Load Testing 
 The breaking load of the 2-octyl cyanoacrylate increased when silver 
nanoparticles were added to the adhesive.  The samples were affixed to the universal 
testing machine clamps and were pulled until the reduced section fractured.  The raw data 
recorded by the Bluehill® 3 software was obtained and analyzed in Microsoft Excel.  
Table 13 displays the average breaking load for each silver nanoparticle concentration 
and size combination, standard deviation, and p-values.  The raw data for the breaking 
load test are located in Appendix D.  Figure 35 is a graph comparing the average 
breaking load of the unaltered adhesive and different composite adhesives with each 
other.  The error bars depict the standard deviation of the set of data for each sample.  
Table 14 summarizes the results of a 2-way ANOVA test from the responses generated in 
the breaking load testing. 
Table 13. The average breaking loads for the different factor combinations.  All runs 
were performed five times.  
 
 
 
 
Name
Average Breaking 
Load (MPa)
Standard 
Deviation p -value
Adhesive Alone 0.46 0.09 N/A
1 μg/mL, 4 nm 
AgNP + Adhesive 0.75 0.09 4.47E-04
10 μg/mL, 10 nm 
AgNP + Adhesive 1.46 0.33 9.46E-05
0.29 9.89E-04
1 μg/mL, 10 nm 
AgNP + Adhesive 0.76 0.19 6.68E-03
10 μg/mL, 4 nm 
AgNP + Adhesive 1.07
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Figure 35. The breaking load results of the different silver nanoparticle concentration and 
size combinations within the tissue adhesive.  Error bars represent the standard deviation 
for each sample combination.  
 
 
Table 14. The results of a 2-way ANOVA test from the responses generated in the 
breaking load testing.  The test statistic, critical value, and p-value are shown for the 
size and concentration factors.  The interaction of the size and concentration factors is 
also shown.  
 
 
 
5.4 Adhesive Force Testing on Porcine Eyes 
 When silver nanoparticles were added to the 2-octyl cyanoacrylate adhesive, the 
adhesive force increased.  Figure 36 shows the fracturing of the adhesive bonds.  The 
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adhesive force was determined by using Microsoft Excel to analyze the raw data 
generated by the Bluehill® 3 software.  Table 15 tabulates the average adhesive force for 
each silver nanoparticle concentration and size combination, standard deviation, and p-
values.  The raw data for the adhesive force test are located in Appendix E.  Figure 37 
compares the average adhesive force of the unaltered adhesive samples to the different 
composite adhesives.  The error bars depict the standard deviation of the set of data for 
each sample.  Table 16 summarizes the results of a 2-way ANOVA test from the 
responses produced in the adhesive force testing. 
 
Figure 36. The broken adhesive bonds after adhesive force testing.  
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Table 15. The average adhesive forces for the various factor combinations.  All runs 
were performed five times.  
 
 
 
 
 
 
Figure 37. The adhesive force results of the various doped and undoped adhesives.  Error 
bars represent the standard deviation for each sample combination. 
Name
Average Adhesive 
Force (MPa)
Standard 
Deviation p -value
Adhesive Alone 0.008 0.002 N/A
1 μg/mL, 4 nm AgNP 
+ Adhesive 0.010 0.001 4.462E-02
4.367E-040.0070.025
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AgNP + Adhesive
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Table 16. The results of a 2-way ANOVA test from the responses produced in the 
adhesive force testing.  The test statistic, critical value, and p-value are shown for the 
size and concentration factors.  The interaction of the size and concentration factors is 
also shown.  
 
 
Source of Variation F F crit p -value
Concentration 18.3 4.49 5.77E-04
Size 4.26 4.49 5.57E-02
Interaction 1.38 4.49 2.57E-01
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CHAPTER SIX 
DISCUSSION 
6.1 Silver Nanoparticle Distribution within Tissue Adhesive 
 The distribution of the silver nanoparticles within the 2-octyl cyanoacrylate tissue 
adhesive can possibly affect the variability of the results.  When mixing the silver 
nanoparticles into the adhesive, silver nanoparticles were positioned in the polymer 
matrix such that it affected the mechanical strength of the adhesive [31,56,57].  If the 
nanoparticles were not uniformly distributed within the polymer matrix, portions of the 
composite sample could possibly possess higher concentrations of the nanoparticles 
whereas other portions could possess lower or minimal concentrations of nanoparticles 
within the matrix.  For the adhesive force testing, the higher nanoparticle concentration 
portion of the sample should require more force to break the adhesive bonds to the 
porcine sclera.  For the breaking load testing, a higher nanoparticle concentration portion 
at the reduced section of the dog-bone specimen should withstand more tensile force 
when the specimen is pulled apart until the reduced section fractures.  In contrast, 
samples containing negligible amounts of silver nanoparticles distributed at certain 
portions of the polymer matrix should experience similar mechanical strength as an 
unaltered version of the tissue adhesive. 
6.2 Antibacterial Efficacy 
 Both the Kirby-Bauer disk diffusion susceptibility test and CFU counting test 
revealed that the silver nanoparticles imbued antibacterial properties to the 2-octyl 
cyanoacrylate tissue adhesive when mixed together.  For the Kirby-Bauer test, an evident 
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inhibition halo surrounded the composite samples where E. coli colonies were not found.  
For the CFU counting test, the silver nanoparticle-doped adhesive significantly reduced 
the number of E. coli colonies grown on the culturing dish.  The difference between 
composite samples and unaltered samples was statistically significant with a p-value less 
than 0.01. 
6.2.1 Kirby-Bauer Disk Diffusion Susceptibility Test 
 There was no inhibition halo surrounding the undoped adhesive samples.  
Imbuing the antibacterial property of silver nanoparticles into the adhesive produced a 
notably clear and distinct inhibition halo around the composite sample.  This is due to the 
absorption of water by the composite adhesive while the silver diffuses into the 
surrounding agar during incubation [26,34].  The silver interacts with the bacterial cells 
to inhibit several cell functions and injure the cells [8,58].  The growth of E. coli was 
inhibited surrounding the sample because the bacteria experienced the antibacterial 
property of the silver nanoparticles.  The magnified microscope images of the samples 
confirmed the inhibition halo around the composite sample and the E. coli growth 
surrounding the unaltered tissue adhesive.  The difference between doped and undoped 
samples was statistically significant with a p-value less than 0.01. 
 The results show that the 10 μg/mL of 4 nm silver nanoparticle-doped adhesive 
demonstrated the greatest bactericidal effect.  With the exception of the inhibition halo 
diameters of the 10 μg/mL of 4 nm silver nanoparticle-doped adhesive, the difference 
between inhibition halo diameters of the all samples was minimal.  A 2-way ANOVA test 
was executed in Microsoft Excel and found that the silver nanoparticle concentration had 
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a significant effect on the inhibition halo diameter results, while there was no significant 
difference between the silver nanoparticle sizes on the results.  The 2-way ANOVA test 
results also showed that there was interaction between silver nanoparticle size and 
concentration, which means that the response to size was dependent on the concentration 
and vice versa.  The effect of silver nanoparticle concentration on antibacterial efficacy 
supported previous research that found an increase of silver nanoparticle concentration 
enhanced antibacterial effectiveness [25].  The minimal difference in antibacterial 
efficacy when varying silver nanoparticle size from 4 nm to 10 nm was possibly due to 
the relatively small difference in nanoparticle size.  Although the doped adhesives 
demonstrated noticeable antibacterial efficacy compared to an unaltered adhesive, a 
definitive conclusion cannot be drawn regarding the influence of the silver nanoparticle 
size on the antibacterial efficacy of the adhesive.  The CFU counting test was employed 
to provide another quantitative measure of the influence silver nanoparticle size and 
concentration has on the 2-octyl cyanoacrylate tissue adhesive. 
6.2.2 CFU Counting 
 The CFU counts supported the results from the Kirby-Bauer disk diffusion 
susceptibility test indicating that silver nanoparticles imparted their antibacterial 
properties to the tissue adhesive.  The original tissue adhesive can only seal and protect 
the wound from environmental bacteria and factors.  The presence of bacteria from an 
improperly cleansed wound will allow bacteria to continue to grow in the wound and 
under the sealing adhesive layer.  Our results show that tissue adhesives doped with silver 
nanoparticles displayed a significant, order of magnitude reduction of bacterial growth 
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than undoped tissue adhesives.  This decrease in bacterial growth reduces the chance of 
bacteria in the wound producing an inflammatory response and possibly leading to 
infection.  If a wound is currently inflamed or infected, the silver nanoparticle-infused 
tissue adhesive can aid in reducing the degree of inflammation or infection by preventing 
bacteria from continual growth and reproduction. 
 The 10-2 dilution of the unaltered adhesive was used for the colony counts 
because the 10-1 dilution culturing dishes were confluent with E. coli and colonies were 
not distinguishable to be easily counted.  In contrast, the culturing dishes containing 
silver nanoparticle-infused adhesive samples were counted at 10-1 dilutions due to the 
relatively defined outline of the colonies and reasonable count.  ImageJ was a reliable 
software to count the number of colonies on each culturing dish; however, like with all 
software and methods, there were some limitations.  The software detected certain 
specified parameters that were included in the colony count.  The color, size, and 
circularity of the colonies were set to the desired specifications.  For this research, the 
color of the E. coli colonies was set to be detected when adjusting the color threshold.  
The size of the colonies was based on choosing the typical smallest colony as the 
minimal pixel size and including colonies larger than the smallest colony as part of the 
count.  Small pixels displayed and detected as the same color as the colonies were 
considered artifactual and were excluded from the count.  The acceptable circularity was 
set to all shapes because E. coli colonies are not consistently circular. 
 The difference in CFU counts between the composite samples and unaltered 
samples was statistically significant with a p-value less than 0.01.  Although the silver 
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nanoparticle-infused tissue adhesive demonstrated an order of magnitude reduction of 
bacterial growth compared to the adhesive alone, the antibacterial effectiveness of the 
four combinations of silver nanoparticle concentration and size varied slightly between 
each other.  A 2-way ANOVA test was performed in Microsoft Excel to determine the 
level of effect the silver nanoparticle size and concentration had on the antibacterial 
effectiveness and if there was interaction between these two factors.  The 2-way ANOVA 
test results showed that there was no significant interaction between silver nanoparticle 
size and concentration, which means that the response to size was not dependent on the 
concentration and vice versa.  There was a negligible difference in antibacterial efficacy 
of the varying size and concentration combinations.  The slight difference in antibacterial 
efficacy when varying the nanoparticle size from 4 nm to 10 nm is possibly due to the 
relatively small difference in nanoparticle size.  A larger difference between nanoparticle 
sizes can possibly better distinguish the effects of silver nanoparticle size on antibacterial 
effectiveness.  The difference in antibacterial efficacy was minimal when silver 
nanoparticle concentration was varied for this CFU counting test.  This is possibly due to 
after reaching certain concentration levels E. coli growth was the same because E. coli 
growth has essentially stopped.  Increasing the silver nanoparticle concentration after 
reaching this concentration threshold level would not further reduce the amount of E. coli 
grown, which was also seen in previous research when performing CFU counts [35].  
Although the difference between the various doped adhesive combinations was minimal, 
the CFU counts showed that a higher concentration of silver nanoparticles within the 
adhesive does reduce the number of bacterial colonies grown.  When increasing the 
88 
 
concentration from 1 μg/mL to 10 μg/mL, the average logarithmic CFU count for the 4 
nm and 10 nm silver nanoparticles were 3.89 to 3.81 and 3.90 and 3.87, respectively.  
Our findings supported previous research that a higher concentration of silver 
nanoparticles increases antibacterial efficacy [25].  Furthermore, the average logarithmic 
CFU counts depict that the smaller silver nanoparticle size showed a greater antibacterial 
effect on bacteria growth than the larger nanoparticle.  This supports previous research 
that the smaller silver nanoparticle size has a greater antibacterial effectiveness than 
larger nanoparticles [35].  The 10 μg/mL of 4 nm silver nanoparticles within the 2-octyl 
cyanoacrylate samples possesses both the high concentration and the small nanoparticle 
size combination.  Our results supported that this combination had the greatest 
antibacterial efficacy among all the tested combinations. 
6.3 Breaking Load Testing 
 The infusion of silver nanoparticles into the 2-octyl cyanoacrylate caused the 
breaking load force of the adhesive to increase.  The average breaking load of the 
unaltered adhesive was 0.46 MPa.  Increasing the silver nanoparticle concentration in the 
adhesive increased the breaking load.  The increased concentration of 4 nm nanoparticles 
from 1 μg/mL to 10 μg/mL showed about an average 0.32 MPa increase in breaking load, 
while the 10 nm nanoparticle concentration increase from 1 μg/mL to 10 μg/mL 
demonstrated about an average 0.7 MPa increase in breaking load of the adhesive.  The 
greatest breaking load was the 10 μg/mL of 10 nm silver nanoparticle-doped adhesive.  
The increased concentration of nanoparticles resulted in an increase of the adhesive’s 
breaking strength, which supported previous research findings that increased mechanical 
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strength were due to the dispersion of more nanoparticles to interact with the polymer 
matrix [31,59]. 
 Increasing the size of the nanoparticles from 4 nm to 10 nm at 1 μg/mL minimally 
increased the breaking load force of the adhesive.  The 10 μg/mL of 4 nm and 10 nm 
showed about an average 0.39 MPa increase in breaking load of the adhesive.  This 
difference in average breaking load may be due to the wider range of responses of these 
samples.  The range of responses for the 1 μg/mL of 4 nm and 10 nm sample 
combinations were narrower.  The difference between the doped and undoped samples 
was statistically significant with a p-value less than 0.01.  A 2-way ANOVA test was 
executed in Microsoft Excel and found that the silver nanoparticle concentration had a 
significant effect on the breaking load results, while there was no significant difference 
between the silver nanoparticle sizes on the results.  The increase of silver nanoparticle 
concentration showed a clearer effect on the mechanical strength of the tissue adhesive, 
but the effect of silver nanoparticle size on the adhesive’s mechanical strength was 
minimal.  The 2-way ANOVA test results also showed that there was no significant 
interaction between silver nanoparticle size and concentration, which means that the 
response to size was not dependent on the concentration and vice versa. 
6.4 Adhesive Force Testing on Porcine Eyes 
 The adhesive force increased when silver nanoparticles were added to the 2-octyl 
cyanoacrylate tissue adhesive.  The average adhesive force of the unaltered adhesive was 
0.008 MPa.  The adhesive force slightly increased to an average of 0.010 MPa when 1 
μg/mL of 4 nm silver nanoparticles was infused into the adhesive.  Increasing the 
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concentration of the silver nanoparticles in the adhesive showed a greater increase of 
adhesive strength.  The adhesive doped with 10 μg/mL of 10 nm silver nanoparticles 
required the most force to fracture the adhesive bonds.  On average, the adhesive strength 
of the adhesives containing 10 μg/mL of 4 nm nanoparticles and 1 μg/mL of 10 nm 
nanoparticles was also greater than the unaltered adhesive and 1 μg/mL of 4 nm 
composite adhesive.  The increased concentration increased the interaction of the 
nanoparticles with the polymer matrix and was expected to enhance the adhesive strength 
of the adhesive [31,59]. 
 The adhesive strength of the 1 μg/mL of 10 nm composite adhesive was higher 
compared to the 1 μg/mL of 4 nm doped adhesive.  This was possibly due to the wider 
range of variability in the results for the 1 μg/mL of 10 nm composite adhesive than the 1 
μg/mL of 4 nm doped adhesive.  The wider range of responses can be attributed to the 
uniqueness of each porcine eye and variability between each other.  The shape of the test 
substrate can be a factor that might affect the bonding of the adhesive.  Even though the 
flat area of the T-structure was firmly pressed and adhered to the porcine eyeball, the 
eyeball might have reverted to its natural spherical shape.  Furthermore, the variation in 
surface morphology of each sclera can contribute to the broad range of responses.  A 2-
way ANOVA test was performed in Microsoft Excel to determine the effect of silver 
nanoparticle concentration and size on the adhesive force and if there was interaction 
between these two factors.  The 2-way ANOVA test results showed that there was no 
significant interaction between silver nanoparticle size and concentration, which means 
that the response to size was not dependent on the concentration and vice versa.  We 
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found that the silver nanoparticle concentration had a significant effect on the adhesive 
force results, while there was a negligible difference between the silver nanoparticle sizes 
on the results.  Because of this 2-way ANOVA test, the results from this experiment 
suggest that the increase of nanoparticle concentration in the adhesive resulted in 
enhanced adhesive strength.  The results from varying nanoparticle sizes were 
comparable among each other.  The difference between the composite samples and 
unaltered samples was statistically significant with a p-value less than 0.05. 
 An increased adhesive strength indicates that the adhesive holding together two 
ends of tissue requires greater force to separate the adhesive bonds.  This is particularly 
important because the adhesive will prevent the two ends of tissue from further 
separation when sudden or excessive force is applied.  Although doping the adhesive with 
silver nanoparticles increased the mechanical strength when tested on the porcine eyes, 
the strength of the adhesive on different tissues in the body can possibly vary because 
adhesive strength is highly dependent on the test substrate [38].  Since 2-octyl 
cyanoacrylate is already used to treat wounds from many areas of the body including the 
eye, the increased adhesive strength of the composite adhesive enhances the performance 
of the adhesive while imparting an antibacterial effect. 
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CHAPTER SEVEN 
CONCLUSION 
 The infusion of silver nanoparticles into a 2-octyl cyanoacrylate tissue adhesive 
does impart an antibacterial effect to the adhesive.  The greatest antibacterial effect came 
from imbuing 10 μg/mL of 4 nm silver nanoparticles into the tissue adhesive, which was 
shown in both the Kirby-Bauer test and CFU counting.  There were distinct inhibition 
halos surrounding each composite sample, whereas there were no halos surrounding 
unaltered samples for the Kirby-Bauer test.  A significant, order of magnitude reduction 
of bacterial growth was seen from the doped adhesive compared to the unaltered adhesive 
when the CFU counting test was performed.  While the addition of silver nanoparticles 
caused a significant reduction in the number of E. coli colonies for the doped adhesives, 
the difference among the varying silver nanoparticle size and concentration combinations 
was minimal. 
 The results of the breaking load test showed the addition of silver nanoparticles 
into the adhesive increased the breaking strength of the adhesive.  The greatest breaking 
load was the 10 μg/mL of 10 nm silver nanoparticle-doped adhesive.  The adhesive 
strength of the adhesive increased when silver nanoparticles were added and applied to 
the incised porcine sclera.  The 10 μg/mL of 10 nm silver nanoparticle-infused adhesive 
also demonstrated the greatest adhesive strength.  The increased adhesive strength 
indicates that the adhesive fastening together two ends of tissue requires greater force to 
break the adhesive bonds. 
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 With the definite antibacterial efficacy and increased mechanical strength of this 
silver nanoparticle-doped adhesive, this silver nanoparticle-infused 2-octyl cyanoacrylate 
tissue adhesive outperforms conventional tissue adhesives.  Decreasing bacterial growth 
in a wound reduces the chance of infection at the wound site.  This also reduces other 
complications associated with infection and minimizes healing time.  Patients will 
experience less discomfort around the wound compared to mechanical fasteners such as 
sutures or staples.  Furthermore, tissue adhesives are more suitable for delicate tissues 
such as the eye, because it is less traumatic to the tissue than rigid fasteners.  Ultimately, 
the silver nanoparticle-infused tissue adhesive investigated in this research can be an 
alternative or supplement to mechanical fasteners, which allows doctors the option to 
select whatever tissue binding method is most appropriate for the situation. 
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CHAPTER EIGHT 
FUTURE WORK 
 Despite the noticeable antibacterial effect of the silver nanoparticle-infused tissue 
adhesive over the unaltered adhesive, there were small differences between the varying 
silver nanoparticle size and concentration combination in terms of antibacterial efficacy.  
Though the results suggest the 10 μg/mL of 4 nm silver nanoparticles within the 2-octyl 
cyanoacrylate possesses a greater bactericidal effect, the antibacterial efficacy was 
marginally better than the other factor combinations.  Future research can be conducted to 
determine if larger size silver nanoparticles in the adhesive continue to affect antibacterial 
efficacy positively or negatively. 
Future research can also be performed to determine the effect of larger size silver 
nanoparticles on the mechanical strength of the adhesive.  Further testing can involve 
examining what silver nanoparticle size and concentration will provide the optimal 
antibacterial and mechanical adhesive composition.  There are many other characteristics 
of this tissue adhesive that can be tested to further understand its properties and its effect 
on other tissue.  This tissue adhesive can be developed to be safe for in vivo use upon the 
completion of additional in-depth research. 
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APPENDIX A 
DISTANCES BETWEEN SILVER NANOPARTICLES 
Label Length (nm) Label Length (nm) Label Length (nm) Label Length (nm)
1 28.01 30 28.48 59 36.96 88 26.66
2 36.59 31 33.07 60 26.09 89 47.52
3 28.48 32 40.57 61 31.77 90 16.65
4 40.16 33 32.66 62 34.02 91 50.59
5 14.22 34 62.59 63 18.88 92 44.31
6 41.36 35 69.79 64 15.92 93 47.05
7 35.67 36 58.55 65 12.64 94 43.93
8 37.27 37 27.53 66 33.87 95 27.17
9 30.70 38 45.39 67 40.42 96 41.20
10 37.82 39 51.03 68 46.38 97 35.83
11 38.36 40 50.38 69 43.74 98 7.94
12 48.24 41 11.41 70 25.06 99 18.34
13 33.07 42 17.13 71 16.09 100 46.79
14 36.53 43 44.71 72 41.74 101 50.53
15 58.18 44 43.91 73 39.16 102 48.45
16 47.95 45 8.70 74 38.19 103 18.36
17 37.82 46 61.40 75 42.79 104 20.02
18 36.25 47 19.64 76 52.26 105 21.17
19 19.37 48 47.53 77 45.23 106 15.75
20 8.40 49 17.93 78 40.75 107 37.28
21 40.03 50 60.68 79 63.95 108 26.01
22 32.90 51 74.46 80 40.88 109 39.69
23 36.02 52 51.56 81 59.49 110 51.90
24 37.82 53 57.91 82 41.36 111 62.34
25 38.01 54 44.09 83 62.07
26 23.88 55 25.68 84 49.33 Mean 37.20
27 50.17 56 20.25 85 23.51 SD 14.41
28 50.75 57 35.98 86 29.74 Min 7.94
29 40.02 58 25.47 87 18.99 Max 74.46
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APPENDIX B 
KIRBY-BAUER DISK DIFFUSION SUSCEPTIBILITY TEST 
 
Name Inhibition Halo 
Diameter (mm)
Average (mm) Standard 
Deviation
p -value
0
0
0
0
0
10
11
11
12
11
14
15
17
17
13
11
12
13
13
12
13
12
11
12
12
12 0.71 1.28E-10
15.2 1.79 3.05E-08
12.2 0.84 4.27E-10
0 0 N/A
11 0.71 2.55E-10
Adhesive Alone
1 μg/mL, 4 nm 
AgNP + Adhesive
10 μg/mL, 4 nm 
AgNP + Adhesive
1 μg/mL, 10 nm 
AgNP + Adhesive
10 μg/mL, 10 nm 
AgNP + Adhesive
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APPENDIX C 
CFU COUNTS 
Name Colonies
Dilution 
Concentration Log Average
Standard 
Deviation
p -value
(Logarithmic)
610 61000 4.79
587 58700 4.77
554 55400 4.74
1225 122500 5.09
995 99500 5.00
760 7600 3.88
680 6800 3.83
520 5200 3.72
1176 11760 4.07
903 9030 3.96
830 8300 3.92
570 5700 3.76
410 4100 3.61
679 6790 3.83
872 8720 3.94
860 8600 3.93
720 7200 3.86
690 6900 3.84
610 6100 3.79
1200 12000 4.08
463 4630 3.67
640 6400 3.81
960 9600 3.98
1158 11580 4.06
654 6540 3.82
10 μg/mL, 10 nm 
AgNP + Adhesive
3.87 0.16 3.66E-06
10 μg/mL, 4 nm 
AgNP + Adhesive
3.81 0.13 1.38E-06
1 μg/mL, 10 nm 
AgNP + Adhesive
3.90 0.11 1.67E-06
Adhesive Alone 4.88 0.16 N/A
1 μg/mL, 4 nm 
AgNP + Adhesive
3.89 0.13 2.44E-06
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APPENDIX D 
BREAKING LOAD TESTING 
Name Breaking Load 
(MPa)
Average (MPa) Standard 
Deviation
p -value
0.59
0.50
0.44
0.36
0.42
0.77
0.89
0.66
0.75
0.69
0.84
0.85
1.15
1.54
0.98
0.78
1.07
0.71
0.59
0.64
1.56
1.70
1.26
0.99
1.79
Adhesive Alone 0.46 0.09 N/A
1 μg/mL, 4 nm 
AgNP + Adhesive
0.75 0.09 4.47E-04
10 μg/mL, 10 nm 
AgNP + Adhesive
1.46 0.33 9.46E-05
10 μg/mL, 4 nm 
AgNP + Adhesive 1.07 0.29 9.89E-04
1 μg/mL, 10 nm 
AgNP + Adhesive
0.76 0.19 6.68E-03
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APPENDIX E 
ADHESIVE FORCE TESTING 
 
Name Adhesive Force 
(MPa)
Average (MPa) Standard 
Deviation
p -value
0.012
0.009
0.007
0.007
0.006
0.011
0.009
0.010
0.009
0.012
0.014
0.021
0.024
0.031
0.026
0.019
0.024
0.016
0.016
0.014
0.022
0.018
0.021
0.029
0.035
Adhesive Alone 0.008 0.002 N/A
1 μg/mL, 4 nm 
AgNP + Adhesive
0.010 0.001 4.46E-02
10 μg/mL, 10 nm 
AgNP + Adhesive
0.025 0.007 4.37E-04
10 μg/mL, 4 nm 
AgNP + Adhesive
0.023 0.006 4.92E-04
1 μg/mL, 10 nm 
AgNP + Adhesive
0.018 0.004 7.82E-04
